BMIQ11
MCID: BDY004
MIFTS: 82

Body Mass Index Quantitative Trait Locus 11 (BMIQ11)

Categories: Bone diseases, Endocrine diseases, Genetic diseases, Metabolic diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Body Mass Index Quantitative Trait Locus 11

MalaCards integrated aliases for Body Mass Index Quantitative Trait Locus 11:

Name: Body Mass Index Quantitative Trait Locus 11 57 28 38
Obesity 57 11 73 28 53 5 41 43 14 38 16 71 31 33
Leanness, Inherited 57 28 5
Obesity, Early-Onset, Susceptibility to 57 5
Obesity, Severe, and Type Ii Diabetes 57 5
Obesity, Susceptibility to, Bmiq11 57 12
Obesity , Susceptibility to 28 5
Obesity, Susceptibility to 57 38
Obesity, Mild, Early-Onset 57 5
Obesity, Association with 57 5
Obesity, Late-Onset 57 5
Obesity, Severe 57 5
Obesity, Not Elsewhere Classified, Body Mass Index Not Elsewhere Classified 33
Obesity, Early-Onset 57
Simple Obesity Nos 33
Obesity Bmiq11 57
Excess Fat 33
Adiposis 33
Bmiq11 57

Classifications:



External Ids:

Disease Ontology 11 DOID:9970
OMIM® 57 300306 601665
ICD9CM 34 278.00
MeSH 43 D009765
NCIt 49 C159658
SNOMED-CT 68 5476005
ICD10 31 E66 E66.0 E66.9
SNOMED-CT via HPO 69 414915002 414916001
UMLS 71 C0028754

Summaries for Body Mass Index Quantitative Trait Locus 11

MedlinePlus: 41 Obesity means having too much body fat. It is different from being overweight, which means weighing too much. The weight may come from muscle, bone, fat, and/or body water. Both terms mean that a person's weight is greater than what's considered healthy for his or her height. Obesity happens over time when you eat more calories than you use. The balance between calories-in and calories-out differs for each person. Factors that might affect your weight include your genetic makeup, overeating, eating high-fat foods, and not being physically active. Obesity increases your risk of diabetes, heart disease, stroke, arthritis, and some cancers. If you have obesity, losing even 5 to 10% of your weight can delay or prevent some of these diseases. For example, that means losing 10 to 20 pounds if you weigh 200 pounds. NIH: National Institute of Diabetes and Digestive and Kidney Diseases

MalaCards based summary: Body Mass Index Quantitative Trait Locus 11, also known as obesity, is related to leptin deficiency or dysfunction and type 2 diabetes mellitus, and has symptoms including symptoms, high weight and obesity, metabolically benign. An important gene associated with Body Mass Index Quantitative Trait Locus 11 is UCP3 (Uncoupling Protein 3), and among its related pathways/superpathways are Beta-2 adrenergic-dependent CFTR expression and Glucose / Energy Metabolism. The drugs Vildagliptin and Lactitol have been mentioned in the context of this disorder. Affiliated tissues include skeletal muscle, liver and heart, and related phenotypes are obesity and decreased resting energy expenditure

Disease Ontology: 11 An overnutrition that is characterized by excess body fat, traditionally defined as an elevated ratio of weight to height (specifically 30 kilograms per meter squared), has material basis in a multifactorial etiology related to excess nutrition intake, decreased caloric utilization, and genetic susceptibility, and possibly medications and certain disorders of metabolism, endocrine function, and mental illness.

UniProtKB/Swiss-Prot: 73 A condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat.

More information from OMIM: 300306 601665

Related Diseases for Body Mass Index Quantitative Trait Locus 11

Diseases in the Body Mass Index Quantitative Trait Locus 11 family:

Body Mass Index Quantitative Trait Locus 9 Body Mass Index Quantitative Trait Locus 8
Body Mass Index Quantitative Trait Locus 1 Body Mass Index Quantitative Trait Locus 2
Body Mass Index Quantitative Trait Locus 3 Body Mass Index Quantitative Trait Locus 4
Body Mass Index Quantitative Trait Locus 10 Body Mass Index Quantitative Trait Locus 7
Body Mass Index Quantitative Trait Locus 5 Body Mass Index Quantitative Trait Locus 6
Body Mass Index Quantitative Trait Locus 12 Body Mass Index Quantitative Trait Locus 13
Body Mass Index Quantitative Trait Locus 14 Body Mass Index Quantitative Trait Locus 15
Body Mass Index Quantitative Trait Locus 18 Body Mass Index Quantitative Trait Locus 19
Body Mass Index Quantitative Trait Locus 20

Diseases related to Body Mass Index Quantitative Trait Locus 11 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 2467, show less)
# Related Disease Score Top Affiliating Genes
1 leptin deficiency or dysfunction 34.5 UCP3 PPARG POMC MC4R GHRL CARTPT
2 type 2 diabetes mellitus 34.3 UCP3 PRMT7 PPARG POMC NR0B2 MIR143
3 diabetes mellitus 33.6 UCP3 PPARG POMC MIR143 MC4R GHRL
4 abdominal obesity-metabolic syndrome 1 33.5 PPARG GHRL ADRB3
5 prediabetes syndrome 33.3 UCP3 PPARG MC4R GHRL ADRB3 ABCC8
6 glucose intolerance 33.3 PPARG POMC GHRL ENPP1 ADRB3 ABCC8
7 hypertension, essential 33.0 PPARG POMC MIR143 MC4R GNAS GHRL
8 eating disorder 33.0 POMC MC4R GHRL AGRP
9 gestational diabetes 33.0 PPARG GHRL ENPP1 ADRB3 ABCC8
10 lipid metabolism disorder 33.0 PPARG POMC GHRL ADRB3 ADRB2
11 prader-willi syndrome 32.9 POMC MC4R GHRL AGRP
12 hyperinsulinism 32.9 UCP3 PPARG MC4R GHRL ABCC8
13 pseudohypoparathyroidism, type ia 32.8 POMC MC4R GNAS
14 hyperglycemia 32.5 PPARG GHRL ADRB3 ABCC8
15 maturity-onset diabetes of the young 32.5 PPARG NR0B2 MC4R GHRL ABCC8
16 overnutrition 32.5 PPARG POMC MIR143 MC4R GHRL AGRP
17 migraine with or without aura 1 32.5 POMC POLG BRCA2 ADRB2
18 sleep apnea 32.4 PPARG MC4R GHRL
19 conn's syndrome 32.4 PPARG POMC GNAS GHRL
20 adult syndrome 32.2 PPARG POMC DNMT3A
21 osteoporosis 32.1 PPARG GNAS GHRL ENPP1 DNMT3A ADRB3
22 anorexia nervosa 32.1 POMC MC4R GHRL AGRP
23 alcohol dependence 32.0 PPARG POMC GHRL CARTPT
24 hypoglycemia 32.0 POMC GHRL ADRB2 ABCC8
25 hyperandrogenism 31.9 PPARG POMC MC4R
26 ovarian disease 31.3 PPARG POMC MIR143 BRCA2
27 multiple endocrine neoplasia, type i 31.3 POMC GNAS GHRL
28 hyperthyroidism 31.3 POMC GNAS GHRL
29 acromegaly 31.0 POMC GNAS GHRL
30 osseous heteroplasia, progressive 31.0 GNAS ENPP1 BRCA2
31 monogenic diabetes 30.5 MC4R ABCC8
32 osteochondrodysplasia 30.5 PRMT7 GNAS ENPP1 ABCC8
33 factitious disorder 30.1 POMC ABCC8
34 nelson syndrome 29.9 PPARG POMC
35 body mass index quantitative trait locus 19 11.9
36 body mass index quantitative trait locus 20 11.9
37 body mass index quantitative trait locus 8 11.9
38 body mass index quantitative trait locus 12 11.9
39 body mass index quantitative trait locus 14 11.9
40 body mass index quantitative trait locus 4 11.9
41 body mass index quantitative trait locus 9 11.8
42 body mass index quantitative trait locus 7 11.8
43 body mass index quantitative trait locus 18 11.8
44 body mass index quantitative trait locus 10 11.8
45 leptin receptor deficiency 11.8
46 obesity, early-onset, with adrenal insufficiency and red hair 11.6
47 obesity-hypoventilation syndrome 11.6
48 intellectual developmental disorder, x-linked, syndromic, wilson-turner type 11.5
49 cohen syndrome 11.5
50 abdominal obesity-metabolic syndrome 3 11.5
51 mehmo syndrome 11.5
52 proprotein convertase 1/3 deficiency 11.5
53 abdominal obesity-metabolic syndrome 4 11.5
54 mental retardation, truncal obesity, retinal dystrophy, and micropenis syndrome 11.5
55 morbid obesity and spermatogenic failure 11.5
56 abdominal obesity-metabolic syndrome quantitative trait locus 2 11.4
57 momo syndrome 11.4
58 chops syndrome 11.4
59 spastic paraplegia, intellectual disability, nystagmus, and obesity 11.4
60 coenzyme q10 deficiency, primary, 2 11.4
61 chung-jansen syndrome 11.4
62 obesity, hyperphagia, and developmental delay 11.4
63 retinal dystrophy and obesity 11.3
64 non-alcoholic fatty liver disease 11.3
65 hypothalamic obesity 11.3
66 fatty liver disease 11.3
67 hydrocephalus obesity hypogonadism 11.3
68 obesity due to sim1 deficiency 11.3
69 coloboma-obesity-hypogenitalism-mental retardation syndrome 11.3
70 aniridia - ptosis - intellectual disability - familial obesity 11.3
71 rohhad 11.3
72 rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome 11.3
73 severe early-onset obesity-insulin resistance syndrome due to sh2b1 deficiency 11.3
74 camera-marugo-cohen syndrome 11.2
75 wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome 11.2
76 mental retardation, obesity, mandibular prognathism, and eye and skin anomalies 11.2
77 ayazi syndrome 11.2
78 short stature, brachydactyly, impaired intellectual development, and seizures 11.2
79 man1b1-cdg 11.2
80 x-linked intellectual disability - short stature - obesity 11.2
81 intellectual disability-obesity-brain malformations-facial dysmorphism syndrome 11.2
82 polycystic ovary syndrome 11.2
83 obesity due to melanocortin 4 receptor deficiency 11.2
84 syndromic x-linked intellectual disability 7 11.2
85 intellectual disability-seizures-macrocephaly-obesity syndrome 11.2
86 body mass index quantitative trait locus 1 11.2
87 alstrom syndrome 11.2
88 genetic non-syndromic obesity 11.2
89 hyperostosis frontalis interna 11.2
90 fatty liver disease 1 11.2
91 biemond syndrome ii 11.2
92 carpenter syndrome 1 11.2
93 borjeson-forssman-lehmann syndrome 11.2
94 bardet-biedl syndrome 1 11.2
95 bardet-biedl syndrome 11.2
96 x-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome 11.2
97 obesity-colitis-hypothyroidism-cardiac hypertrophy-developmental delay syndrome 11.2
98 heart disease 11.1
99 bardet-biedl syndrome 2 11.1
100 clark-baraitser syndrome 11.1
101 genetic obesity 11.1
102 bardet-biedl syndrome 3 11.1
103 asthma 11.1
104 hypertriglyceridemia 1 11.1
105 rickets 11.1
106 gallbladder disease 1 11.1
107 bardet-biedl syndrome 10 11.1
108 bardet-biedl syndrome 11 11.1
109 bardet-biedl syndrome 12 11.1
110 bardet-biedl syndrome 4 11.1
111 pre-eclampsia 11.0
112 chromosome 16p11.2 deletion syndrome, 220-kb 11.0
113 retinohepatoendocrinologic syndrome 11.0
114 ulnar-mammary syndrome 11.0
115 nutritional deficiency disease 11.0
116 vascular disease 11.0
117 bile acid synthesis defect, congenital, 2 11.0
118 cholestasis, benign recurrent intrahepatic, 1 11.0
119 bile acid synthesis defect, congenital, 1 11.0
120 laron syndrome 11.0
121 oto-palatal-digital syndrome 11.0
122 bardet-biedl syndrome 6 11.0
123 wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome 11.0
124 short stature-obesity syndrome 11.0
125 adiposis dolorosa 11.0
126 bardet-biedl syndrome 9 11.0
127 prolactin deficiency with obesity and enlarged testes 11.0
128 colorectal cancer 11.0
129 breast cancer 11.0
130 pseudopseudohypoparathyroidism 11.0
131 bardet-biedl syndrome 5 11.0
132 bardet-biedl syndrome 7 11.0
133 bardet-biedl syndrome 8 11.0
134 bardet-biedl syndrome 21 11.0
135 syndromic obesity 11.0
136 apnea, obstructive sleep 11.0
137 prader-willi habitus, osteopenia, and camptodactyly 11.0
138 chromosome 2q37 deletion syndrome 11.0
139 pseudohypoparathyroidism, type ic 11.0
140 rafiq syndrome 11.0
141 bardet-biedl syndrome 22 11.0
142 bardet-biedl syndrome 20 11.0
143 acquired metabolic disease 10.9 PPARG POMC MIR143 MC4R GHRL AGRP
144 hepatocellular carcinoma 10.9
145 stroke, ischemic 10.9
146 congestive heart failure 10.9
147 pulmonary embolism 10.9
148 pituitary adenoma 4, acth-secreting 10.9
149 schaaf-yang syndrome 10.9
150 renal cell carcinoma, nonpapillary 10.9
151 achondroplasia 10.9
152 obesity due to congenital leptin resistance 10.9
153 bdv syndrome 10.9
154 cardiovascular system disease 10.9
155 gout 10.9
156 focal segmental glomerulosclerosis 10.9
157 oculodentodigital dysplasia 10.9
158 liver disease 10.9
159 atkin-flaitz syndrome 10.9
160 bardet-biedl syndrome 14 10.9
161 hypogonadotropic hypogonadism 27 without anosmia 10.9
162 chromosome 16p11.2 deletion syndrome 10.9
163 neural tube defects 10.9
164 hernia, hiatus 10.9
165 acrodysostosis 1 with or without hormone resistance 10.9
166 chromosome 16p12.1 deletion syndrome, 520-kb 10.9
167 intellectual developmental disorder, x-linked, syndromic 11 10.9
168 intellectual developmental disorder, x-linked, syndromic, nascimento type 10.9
169 aromatase deficiency 10.9
170 chromosome 16p12.2-p11.2 deletion syndrome, 7.1- to 8.7-mb 10.9
171 carpenter syndrome 2 10.9
172 pigmented nodular adrenocortical disease, primary, 4 10.9
173 bardet-biedl syndrome 13 10.9
174 bardet-biedl syndrome 16 10.9
175 bardet-biedl syndrome 17 10.9
176 bardet-biedl syndrome 18 10.9
177 bardet-biedl syndrome 19 10.9
178 temple syndrome 10.9
179 intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures 10.9
180 cortisone reductase deficiency 10.9
181 x-linked intellectual disability-short stature-overweight syndrome 10.9
182 hernández-aguirre negrete syndrome 10.9
183 thumb stiffness-brachydactyly-intellectual disability syndrome 10.9
184 ovarian cancer 10.9
185 intellectual developmental disorder, autosomal dominant 39 10.9
186 esophageal cancer 10.9
187 midface hypoplasia, obesity, developmental delay, and neonatal hypotonia 10.8
188 hypercholesterolemia, familial, 1 10.8
189 genetic overgrowth/obesity syndrome 10.8
190 overgrowth/obesity syndrome 10.8
191 early-onset obesity-hyperphagia-severe developmental delay syndrome 10.8
192 primary hypomagnesemia-generalized seizures-intellectual disability-obesity syndrome 10.8
193 varicose veins 10.8
194 heart valve disease 10.8
195 myeloma, multiple 10.8
196 coronary heart disease 1 10.8
197 pseudohypoparathyroidism 10.8
198 polycystic ovary syndrome 1 10.8
199 non-alcoholic steatohepatitis 10.8
200 type 1 diabetes mellitus 10.8
201 congenital hemidysplasia with ichthyosiform erythroderma and limb defects 10.8
202 children's interstitial lung disease 10.8
203 hidradenitis suppurativa 10.8
204 mckusick-kaufman syndrome 10.8
205 blount's disease 10.8
206 prostate disease 10.8
207 hypersomnia 10.8
208 empty sella syndrome 10.8
209 gastroesophageal reflux 10.8
210 bulimia nervosa 10.8
211 alopecia, androgenetic, 1 10.8
212 hyperlipoproteinemia, type iv 10.8
213 coronary artery disease, autosomal dominant, 1 10.8
214 chromosome 16p13.3 deletion syndrome, proximal 10.8
215 lipodystrophy, familial partial, type 2 10.8
216 acth-independent macronodular adrenal hyperplasia 10.8
217 intellectual developmental disorder, x-linked, syndromic, cabezas type 10.8
218 chromosome 16p11.2 deletion syndrome, 593-kb 10.8
219 bell's palsy 10.8
220 froelich syndrome 10.8
221 williams-beuren syndrome 10.7
222 chromosome xq21 deletion syndrome 10.7
223 renal cell carcinoma, papillary, 1 10.7
224 neutral lipid storage disease with myopathy 10.7
225 white-sutton syndrome 10.7
226 mitochondrial complex iv deficiency, nuclear type 14 10.7
227 t2-low asthma 10.7
228 carcinosarcoma 10.7
229 familial colorectal cancer 10.7
230 atherosclerosis susceptibility 10.7
231 kidney disease 10.7
232 chronic kidney disease 10.7
233 osteoarthritis 10.7
234 pituitary adenoma 1, multiple types 10.7
235 ankylosing vertebral hyperostosis with tylosis 10.7
236 hepatitis b vaccine, response to 10.7
237 precocious puberty, central, 1 10.7
238 septooptic dysplasia 10.7
239 thumbs, stiff, with brachydactyly type a1 and developmental delay 10.7
240 acrocephalopolysyndactyly type iv 10.7
241 summitt syndrome 10.7
242 chromosome xq28 duplication syndrome 10.7
243 chromosome xq27.3-q28 duplication syndrome 10.7
244 high density lipoprotein cholesterol level quantitative trait locus 1 10.7
245 lipodystrophy, familial partial, type 1 10.7
246 pigmented nodular adrenocortical disease, primary, 2 10.7
247 pigmented nodular adrenocortical disease, primary, 1 10.7
248 chromosome 3q29 duplication syndrome 10.7
249 pigmented nodular adrenocortical disease, primary, 3 10.7
250 combined oxidative phosphorylation deficiency 15 10.7
251 precocious puberty, central, 2 10.7
252 helsmoortel-van der aa syndrome 10.7
253 acth-independent macronodular adrenal hyperplasia 2 10.7
254 bardet-biedl syndrome 15 10.7
255 senior-loken syndrome 9 10.7
256 luscan-lumish syndrome 10.7
257 chromosome 13q33-q34 deletion syndrome 10.7
258 radio-tartaglia syndrome 10.7
259 joubert syndrome 40 10.7
260 syndromic x-linked intellectual disability shashi type 10.7
261 cerebrooculofacioskeletal syndrome 10.7
262 rectosigmoid junction neoplasm 10.7
263 pelvic lipomatosis 10.7
264 acth-secreting pituitary adenoma 10.7
265 48,xxyy syndrome 10.7
266 lipodermatosclerosis 10.7
267 proximal chromosome 18q deletion syndrome 10.7
268 hyperandrogenism due to cortisone reductase deficiency 10.7
269 6q16 microdeletion syndrome 10.7
270 hypogonadotropic hypogonadism-retinitis pigmentosa syndrome 10.7
271 ring chromosome y syndrome 10.7
272 intellectual disability-facial dysmorphism-hand anomalies syndrome 10.7
273 xp22.13p22.2 duplication syndrome 10.7
274 11p15.4 microduplication syndrome 10.7
275 17q24.2 microdeletion syndrome 10.7
276 pituitary deficiency due to empty sella turcica syndrome 10.7
277 paternal uniparental disomy of chromosome 20 10.7
278 major depressive disorder 10.7
279 covid-19 10.7
280 growth hormone secreting pituitary adenoma 10.7 POMC GNAS GHRL
281 hyperlipoproteinemia, type i 10.7
282 endometrial cancer 10.7
283 hypogonadism 10.7
284 hypolipoproteinemia 10.7
285 respiratory failure 10.7
286 infertility 10.7
287 aging 10.6
288 acth-independent macronodular adrenal hyperplasia 1 10.6 POMC GNAS
289 thrombophilia due to thrombin defect 10.6
290 basophil adenoma 10.6 POMC GNAS
291 attention deficit-hyperactivity disorder 10.6
292 hypothyroidism 10.6
293 familial hyperlipidemia 10.6
294 49, xxxxy syndrome 10.6
295 anxiety 10.6
296 lipoprotein quantitative trait locus 10.6
297 end stage renal disease 10.6
298 hyperuricemia 10.6
299 periodontitis 10.6
300 ceroid lipofuscinosis, neuronal, 5 10.6
301 down syndrome 10.6
302 specific learning disability 10.6 DNMT3A BBIP1
303 sleep disorder 10.6
304 pulmonary disease, chronic obstructive 10.6
305 cerebrovascular disease 10.6
306 atrial fibrillation 10.6
307 iron metabolism disease 10.6
308 hyperlipoproteinemia, type iii 10.6
309 arteries, anomalies of 10.5
310 myocardial infarction 10.5
311 dowling-degos disease 1 10.5 POMC GNAS
312 dental caries 10.5
313 microvascular complications of diabetes 5 10.5
314 severe covid-19 10.5
315 nephrolithiasis, calcium oxalate 10.5
316 bone mineral density quantitative trait locus 15 10.5
317 bone mineral density quantitative trait locus 8 10.5
318 hypothyroidism, congenital, nongoitrous, 1 10.5
319 acanthosis nigricans 10.5
320 alcohol use disorder 10.5
321 maturity-onset diabetes of the young, type 1 10.5
322 adult respiratory distress syndrome 10.5
323 enterocele 10.5
324 psoriasis 2 10.5
325 liver cirrhosis 10.5
326 psoriasis 1 10.5
327 psoriasis 7 10.5
328 psoriasis 11 10.5
329 psoriasis 13 10.5
330 severe acute respiratory syndrome 10.5
331 psoriasis 10.5
332 personality disorder 10.5
333 esophagus adenocarcinoma 10.5
334 coloboma of optic nerve 10.5
335 colonic benign neoplasm 10.5
336 ataxia with vitamin e deficiency 10.5
337 arthritis 10.5
338 mood disorder 10.5
339 prostate cancer 10.5
340 esophagitis 10.5
341 hair whorl 10.5
342 autism spectrum disorder 10.5
343 eclampsia 10.5
344 impotence 10.5
345 keratomalacia 10.5
346 kidney cancer 10.5
347 hypoascorbemia 10.5
348 gallbladder disease 10.5
349 tatton-brown-rahman syndrome 10.5
350 insulin-like growth factor i 10.5
351 microvascular complications of diabetes 1 10.5
352 cone-rod dystrophy 2 10.5
353 leukemia, acute lymphoblastic 10.5
354 inflammatory bowel disease 10.5
355 bipolar disorder 10.5
356 rhabdomyosarcoma 2 10.5
357 pulmonary hypertension 10.5
358 proteasome-associated autoinflammatory syndrome 1 10.5
359 acute pancreatitis 10.5
360 pancreatic cancer 10.5
361 adenocarcinoma 10.5
362 turner syndrome 10.5
363 47 xxx syndrome 10.5
364 overgrowth syndrome 10.5
365 rheumatoid arthritis 10.5
366 prostate cancer, hereditary, 8 10.4
367 barrett esophagus 10.4
368 deficiency anemia 10.4
369 prostate cancer, hereditary, 6 10.4
370 adenoma 10.4
371 cytokine deficiency 10.4
372 pancreatitis 10.4
373 disease of mental health 10.4
374 craniopharyngioma 10.4
375 microvascular complications of diabetes 2 10.4
376 nephrolithiasis 10.4
377 lung disease 10.4
378 intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies 10.4
379 alzheimer disease, familial, 1 10.4
380 neurodegeneration with brain iron accumulation 2a 10.4
381 microvascular complications of diabetes 3 10.4
382 neuropathy 10.4
383 microvascular complications of diabetes 4 10.4
384 microvascular complications of diabetes 6 10.4
385 microvascular complications of diabetes 7 10.4
386 acute myocardial infarction 10.4
387 chronic pain 10.4
388 peripheral vascular disease 10.4
389 back pain 10.4
390 intracranial hypertension, idiopathic 10.4
391 rapidly involuting congenital hemangioma 10.4
392 cholelithiasis 10.4
393 ige responsiveness, atopic 10.4
394 autism 10.4
395 anovulation 10.4
396 viral infectious disease 10.4
397 progressive non-infectious anterior vertebral fusion 10.4
398 spondyloarthropathy 1 10.4
399 tobacco addiction 10.4
400 hypothyroidism, congenital, nongoitrous, 2 10.4
401 arteriosclerosis 10.4
402 thyroid carcinoma 10.4
403 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.4
404 hypothyroidism, congenital, nongoitrous, 3 10.4
405 male infertility 10.4
406 collecting duct carcinoma 10.4
407 hereditary lymphedema i 10.4
408 bowel dysfunction 10.4
409 charge syndrome 10.4
410 fetal macrosomia 10.4
411 dementia 10.4
412 rectum cancer 10.4
413 intracranial hypertension 10.4
414 gastrointestinal system disease 10.4
415 rectal benign neoplasm 10.4
416 cardiac conduction defect 10.4
417 schizophrenia 10.4
418 autoimmune disease 10.4
419 parkinson disease, late-onset 10.4
420 hypoalphalipoproteinemia, primary, 1 10.4
421 post-traumatic stress disorder 10.4
422 arthropathy 10.4
423 hepatitis 10.4
424 gastric antral vascular ectasia 10.4
425 diarrhea 10.4
426 hypopituitarism 10.4
427 influenza 10.4
428 allergic asthma 10.4
429 hyperparathyroidism 10.3
430 rhinitis 10.3
431 chronic rhinitis 10.3
432 hypotonia 10.3
433 hypogonadotropic hypogonadism 10.3
434 leukemia 10.3
435 spinal cord injury 10.3
436 psoriatic arthritis 10.3
437 gastric cancer 10.3
438 childhood-onset asthma 10.3
439 pik3ca-related overgrowth spectrum 10.3
440 headache 10.3
441 pik3ca-related overgrowth syndrome 10.3
442 neuraminidase deficiency 10.3
443 resting heart rate, variation in 10.3
444 angina pectoris 10.3
445 urinary tract infection 10.3
446 dermatitis, atopic 10.3
447 thrombosis 10.3
448 peripheral nervous system disease 10.3
449 colorectal adenoma 10.3
450 childhood acute lymphocytic leukemia 10.3
451 dermatitis 10.3
452 substance abuse 10.3
453 amyloidosis 10.3
454 hyperphenylalaninemia, bh4-deficient, a 10.3
455 allergic rhinitis 10.3
456 hypokalemia 10.3
457 pneumonia 10.3
458 polysubstance abuse 10.3
459 short stature, onychodysplasia, facial dysmorphism, and hypotrichosis 10.3
460 common cold 10.3
461 hepatitis c 10.3
462 skin disease 10.3
463 lymphoma, hodgkin, classic 10.3
464 graves disease 1 10.3
465 prostatic hyperplasia, benign 10.3
466 crohn's disease 10.3
467 hypogonadotropic hypogonadism 7 with or without anosmia 10.3
468 fanconi anemia, complementation group e 10.3
469 gastritis 10.3
470 48,xyyy 10.3
471 celiac disease 1 10.3
472 precocious puberty 10.3
473 pituitary-dependent cushing's disease 10.3
474 neural tube defects, folate-sensitive 10.3
475 bone disease 10.3
476 cholecystitis 10.3
477 gastroparesis 10.3
478 ovarian cancer 1 10.3
479 lymphoma 10.3
480 b-lymphoblastic leukemia/lymphoma 10.3
481 melanoma 10.3
482 inflammatory bowel disease 1 10.3
483 mismatch repair cancer syndrome 1 10.3
484 amenorrhea 10.3
485 muscular atrophy 10.3
486 congenital central hypoventilation syndrome 10.3
487 allergic disease 10.3
488 encephalopathy 10.3
489 systemic lupus erythematosus 10.2
490 hypoalphalipoproteinemia, primary, 2 10.2
491 ischemia 10.2
492 pancreatic ductal adenocarcinoma 10.2
493 irritable bowel syndrome 10.2
494 multiple sclerosis 10.2
495 niemann-pick disease, type c1 10.2
496 helicobacter pylori infection 10.2
497 colitis 10.2
498 urolithiasis 10.2
499 secondary hyperparathyroidism 10.2
500 peptic esophagitis 10.2
501 psychotic disorder 10.2
502 peritonitis 10.2
503 papillon-lefevre syndrome 10.2
504 cerebral palsy 10.2
505 bladder cancer 10.2
506 ectodermal dysplasia-syndactyly syndrome 2 10.2
507 alexithymia 10.2
508 nephrotic syndrome 10.2
509 lipomatosis 10.2
510 lupus erythematosus 10.2
511 pulmonary hypertension, primary, 1 10.2
512 acute insulin response 10.2
513 hyperprolactinemia 10.2
514 cardiac arrest 10.2
515 toxic shock syndrome 10.2
516 ulcerative colitis 10.2
517 growth hormone deficiency 10.2
518 central hypoventilation syndrome, congenital, 1 10.2
519 microphthalmia, syndromic 9 10.2
520 huntington disease-like 2 10.2
521 dumping syndrome 10.2
522 aortic aneurysm 10.2
523 acne 10.2
524 peptic ulcer disease 10.2
525 periodontitis, chronic 10.2
526 toe syndactyly, telecanthus, and anogenital and renal malformations 10.2
527 aortic valve disease 2 10.2
528 fibromyalgia 10.2
529 twin-reversed arterial perfusion sequence 10.2
530 premature ovarian failure 7 10.2
531 vitamin k deficiency bleeding 10.2
532 bronchitis 10.2
533 diverticulitis 10.2
534 aortic aneurysm, familial abdominal, 1 10.2
535 intussusception 10.2
536 systemic lupus erythematosus 1 10.2
537 hemorrhage, intracerebral 10.2
538 immunodeficiency, common variable, 10 10.2
539 gastric ulcer 10.2
540 wernicke encephalopathy 10.2
541 acute kidney failure 10.2
542 narcolepsy 10.2
543 intervertebral disc disease 10.2
544 glucose/galactose malabsorption 10.2
545 hypertension, diastolic 10.2
546 helix syndrome 10.2
547 cartilage disease 10.2
548 primary hyperoxaluria 10.2
549 ileus 10.2
550 learning disability 10.2
551 systolic heart failure 10.2
552 lung cancer 10.2
553 leukemia, acute myeloid 10.2
554 muscle hypertrophy 10.2
555 mild cognitive impairment 10.2
556 meningocele 10.2
557 b-cell lymphoma 10.2
558 appendicitis 10.2
559 disorder of glyoxylate metabolism 10.2
560 contractures, pterygia, and spondylocarpotarsal fusion syndrome 1a 10.2
561 thyrotropin-releasing hormone deficiency 10.2
562 masa syndrome 10.2
563 simpson-golabi-behmel syndrome, type 1 10.2
564 cerebellar atrophy, developmental delay, and seizures 10.2
565 vitamin b12 deficiency 10.2
566 autonomic neuropathy 10.2
567 dilated cardiomyopathy 10.2
568 reading disorder 10.2
569 hepatitis b 10.2
570 acute myeloid leukemia with recurrent genetic anomaly 10.2
571 ovarian epithelial cancer 10.2
572 burkitt lymphoma 10.2
573 pelvic organ prolapse 10.2
574 hypogonadism, male 10.2
575 sexual health disorder 10.2
576 central diabetes insipidus 10.2
577 venous insufficiency 10.2
578 polyneuropathy 10.2
579 viral hepatitis 10.2
580 diabetes insipidus 10.2
581 postpartum depression 10.2
582 epiphysiolysis of the hip 10.2
583 carpal tunnel syndrome 10.1
584 thyroid cancer, nonmedullary, 1 10.1
585 fetal akinesia deformation sequence 1 10.1
586 polydactyly 10.1
587 mononeuropathy of the median nerve, mild 10.1
588 leukemia, acute lymphoblastic 3 10.1
589 severe combined immunodeficiency 10.1
590 hemophilia 10.1
591 primary agammaglobulinemia 10.1
592 premature aging 10.1
593 lipomatosis, multiple 10.1
594 cardiomyopathy, familial hypertrophic, 1 10.1
595 trichohepatoenteric syndrome 1 10.1
596 macular degeneration, age-related, 1 10.1
597 cervical cancer 10.1
598 lymphoma, non-hodgkin, familial 10.1
599 scoliosis 10.1
600 hypertrophic cardiomyopathy 10.1
601 brain cancer 10.1
602 epilepsy 10.1
603 gingivitis 10.1
604 thyroiditis 10.1
605 cataract 10.1
606 hypervitaminosis d 10.1
607 diaphragmatic hernia, congenital 10.1
608 immune deficiency disease 10.1
609 anemia, sideroblastic, and spinocerebellar ataxia 10.1
610 spastic paraplegia, ataxia, and mental retardation 10.1
611 renal fibrosis 10.1
612 hydrocephalus 10.1
613 iron deficiency anemia 10.1
614 gallbladder cancer 10.1
615 polycythemia 10.1
616 hashimoto thyroiditis 10.1
617 otitis media 10.1
618 pancreatitis, hereditary 10.1
619 gastroschisis 10.1
620 hemophilia a 10.1
621 huntington disease-like 3 10.1
622 human immunodeficiency virus type 1 10.1
623 pain agnosia 10.1
624 endogenous depression 10.1
625 skin carcinoma 10.1
626 panic disorder 10.1
627 paraplegia 10.1
628 degenerative disc disease 10.1
629 achalasia 10.1
630 cardiogenic shock 10.1
631 pachyonychia congenita 1 10.1
632 cryptorchidism, unilateral or bilateral 10.1
633 retinitis pigmentosa 10.1
634 meningioma, familial 10.1
635 henoch-schoenlein purpura 10.1
636 peripheral retinal degeneration 10.1
637 iga glomerulonephritis 10.1
638 cellulitis 10.1
639 pituitary adenoma 10.1
640 insulinoma 10.1
641 acute stress disorder 10.1
642 spondylitis 10.1
643 intestinal obstruction 10.1
644 retinal degeneration 10.1
645 intermediate coronary syndrome 10.1
646 dentinogenesis imperfecta 1 10.1
647 iga nephropathy 1 10.1
648 obsessive-compulsive disorder 10.1
649 cystic fibrosis 10.1
650 bone mineral density quantitative trait locus 3 10.1
651 aica-ribosuria due to atic deficiency 10.1
652 smoking as a quantitative trait locus 3 10.1
653 sensorineural hearing loss 10.1
654 aortic atherosclerosis 10.1
655 hypertensive heart disease 10.1
656 coronary stenosis 10.1
657 decubitus ulcer 10.1
658 cryptogenic cirrhosis 10.1
659 tuberous sclerosis 1 10.1
660 vertical talus, congenital 10.1
661 hutterite cerebroosteonephrodysplasia syndrome 10.1
662 arts syndrome 10.1
663 secondary progressive multiple sclerosis 10.1
664 peripheral artery disease 10.1
665 transient cerebral ischemia 10.1
666 hidradenitis 10.1
667 synovitis 10.1
668 gastric adenocarcinoma 10.1
669 pituitary gland disease 10.1
670 schizoaffective disorder 10.1
671 skin tag 10.1
672 vascular dementia 10.1
673 muscular dystrophy 10.1
674 hypereosinophilic syndrome 10.1
675 fetal anticonvulsant syndrome 10.1
676 factor viii deficiency 10.1
677 glioma susceptibility 1 10.1
678 hyperhomocysteinemia 10.1
679 bacteremia 2 10.1
680 fetal akinesia deformation sequence 2 10.1
681 chronic venous insufficiency 10.1
682 endometritis 10.1
683 microcephaly 10.1
684 goiter 10.1
685 conduct disorder 10.1
686 beriberi 10.1
687 familial hypercholesterolemia 10.1
688 pancreatic adenocarcinoma 10.1
689 eye disease 10.1
690 acquired immunodeficiency syndrome 10.1
691 diffuse idiopathic skeletal hyperostosis 10.1
692 myeloid leukemia 10.1
693 diabetic neuropathy 10.1
694 drug dependence 10.1
695 cerebrospinal fluid leak 10.1
696 traumatic brain injury 10.1
697 neutrophilia, hereditary 10.0
698 tendinopathy 10.0
699 endometrial hyperplasia 10.0
700 gynecomastia 10.0
701 persistent fetal circulation syndrome 10.0
702 cholestasis 10.0
703 duodenal ulcer 10.0
704 exostosis 10.0
705 bilirubin metabolic disorder 10.0
706 food allergy 10.0
707 neuromuscular disease 10.0
708 idiopathic hypersomnia 10.0
709 glomerular disease 10.0
710 hyperlipidemia, familial combined, 3 10.0
711 lipoid congenital adrenal hyperplasia 10.0
712 carnitine palmitoyltransferase ii deficiency, infantile 10.0
713 propionic acidemia 10.0
714 chorioamnionitis 10.0
715 diffuse large b-cell lymphoma 10.0
716 metabolic acidosis 10.0
717 central precocious puberty 10.0
718 osteomalacia 10.0
719 dysthymic disorder 10.0
720 hematologic cancer 10.0
721 endometriosis 10.0
722 bladder disease 10.0
723 scrapie 10.0
724 alopecia 10.0
725 klebsiella infection 10.0
726 ciliopathy 10.0
727 hypervitaminosis a 10.0
728 retinoblastoma 10.0
729 wilms tumor 1 10.0
730 spondylometaphyseal dysplasia, sedaghatian type 10.0
731 thyroid hormone resistance, generalized, autosomal recessive 10.0
732 mend syndrome 10.0
733 wilms tumor 5 10.0
734 leukemia, chronic myeloid 10.0
735 prostate cancer, hereditary, 7 10.0
736 preterm premature rupture of the membranes 10.0
737 adiponectin, serum level of, quantitative trait locus 1 10.0
738 cholangiocarcinoma 10.0
739 portal hypertension 10.0
740 premature menopause 10.0
741 social phobia 10.0
742 dengue disease 10.0
743 filarial elephantiasis 10.0
744 acute leukemia 10.0
745 papilledema 10.0
746 hypothalamic disease 10.0
747 hyperostosis 10.0
748 retinal vascular disease 10.0
749 interstitial lung disease 10.0
750 toxic encephalopathy 10.0
751 retinitis 10.0
752 esophagus squamous cell carcinoma 10.0
753 movement disease 10.0
754 elephantiasis 10.0
755 myocarditis 10.0
756 pathologic nystagmus 10.0
757 diastolic heart failure 10.0
758 hypoalphalipoproteinemia 10.0
759 episodic ataxia, type 2 10.0
760 lipomatosis, multiple symmetric 10.0
761 optic atrophy 1 10.0
762 pheochromocytoma 10.0
763 ocular motor apraxia 10.0
764 taqi polymorphism 10.0
765 thoracoabdominal syndrome 10.0
766 hepatitis c virus 10.0
767 diabetes mellitus, ketosis-prone 10.0
768 tuberous sclerosis 2 10.0
769 pregnancy loss, recurrent 1 10.0
770 restless legs syndrome 10.0
771 estrogen-receptor positive breast cancer 10.0
772 long covid 10.0
773 nephrosclerosis 10.0
774 neutropenia 10.0
775 atypical depressive disorder 10.0
776 graves' disease 10.0
777 estrogen excess 10.0
778 thrombocytopenia 10.0
779 squamous cell carcinoma 10.0
780 autoimmune hepatitis 10.0
781 thrombophilia 10.0
782 plague 10.0
783 intermittent claudication 10.0
784 gastric cardia adenocarcinoma 10.0
785 fundus dystrophy 10.0
786 chronic fatigue syndrome 10.0
787 parasitic helminthiasis infectious disease 10.0
788 placental abruption 10.0
789 developmental coordination disorder 10.0
790 acute mountain sickness 10.0
791 carcinoid tumors, intestinal 10.0
792 hypophosphatasia, adult 10.0
793 leukemia, chronic lymphocytic 10.0
794 sarcoidosis 1 10.0
795 smith-magenis syndrome 10.0
796 tetralogy of fallot 10.0
797 volvulus of midgut 10.0
798 deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome 10.0
799 leukoencephalopathy, hereditary diffuse, with spheroids 1 10.0
800 laurence-moon syndrome 10.0
801 phenylketonuria 10.0
802 dental anomalies and short stature 10.0
803 gastrointestinal stromal tumor 10.0
804 mycobacterium tuberculosis 1 10.0
805 sarcoidosis 2 10.0
806 graft-versus-host disease 10.0
807 female breast cancer 10.0
808 limb ischemia 10.0
809 aortic dissection 10.0
810 acute asthma 10.0
811 renal hypertension 10.0
812 sarcoma 10.0
813 diphtheria 10.0
814 visual epilepsy 10.0
815 azoospermia 10.0
816 generalized anxiety disorder 10.0
817 keratosis 10.0
818 glomerulonephritis 10.0
819 breast disease 10.0
820 lactic acidosis 10.0
821 radiculopathy 10.0
822 compartment syndrome 10.0
823 situs inversus 10.0
824 neuroblastoma 10.0
825 cholangitis 10.0
826 dextrocardia with situs inversus 10.0
827 soft tissue sarcoma 10.0
828 inherited retinal disorder 10.0
829 aniridia 1 9.9
830 aromatase excess syndrome 9.9
831 leiomyoma, uterine 9.9
832 narcolepsy 1 9.9
833 polycystic kidney disease 1 with or without polycystic liver disease 9.9
834 small cell cancer of the lung 9.9
835 spondylolisthesis 9.9
836 hypophosphatasia, infantile 9.9
837 pituitary hormone deficiency, combined, 2 9.9
838 hyperinsulinemic hypoglycemia, familial, 2 9.9
839 sickle cell anemia 9.9
840 aortic valve disease 3 9.9
841 aspiration pneumonia 9.9
842 exanthem 9.9
843 brachydactyly 9.9
844 inguinal hernia 9.9
845 umbilical hernia 9.9
846 polycystic kidney disease 9.9
847 short bowel syndrome 9.9
848 chlamydia 9.9
849 pyelonephritis 9.9
850 primary biliary cholangitis 9.9
851 varicocele 9.9
852 alcoholic hepatitis 9.9
853 quadriplegia 9.9
854 severe pre-eclampsia 9.9
855 alcoholic liver cirrhosis 9.9
856 bipolar i disorder 9.9
857 neuroendocrine tumor 9.9
858 optic nerve disease 9.9
859 carbohydrate metabolic disorder 9.9
860 spinal cord disease 9.9
861 purpura 9.9
862 superior mesenteric artery syndrome 9.9
863 myopathy 9.9
864 syringocystadenoma papilliferum 9.9
865 spinal stenosis 9.9
866 dyskinesia of esophagus 9.9
867 fasciitis 9.9
868 substance dependence 9.9
869 paresthesia 9.9
870 tremor 9.9
871 cleft palate, isolated 9.9
872 hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome 9.9
873 aplasia of lacrimal and salivary glands 9.9
874 strabismus 9.9
875 hydrocephalus, congenital, 1 9.9
876 3-methylglutaconic aciduria, type iii 9.9
877 lysosomal acid lipase deficiency 9.9
878 androgen insensitivity syndrome 9.9
879 intraocular pressure quantitative trait locus 9.9
880 kawasaki disease 9.9
881 ectodermal dysplasia-syndactyly syndrome 1 9.9
882 idiopathic scoliosis 9.9
883 adenoid hypertrophy 9.9
884 physical disorder 9.9
885 antisynthetase syndrome 9.9
886 critical covid-19 9.9
887 blind loop syndrome 9.9
888 hypertrophy of breast 9.9
889 primary hyperparathyroidism 9.9
890 autonomic nervous system disease 9.9
891 portal vein thrombosis 9.9
892 protein-energy malnutrition 9.9
893 prostatitis 9.9
894 blood platelet disease 9.9
895 spondylosis 9.9
896 colon adenocarcinoma 9.9
897 endometrial adenocarcinoma 9.9
898 pulmonary fibrosis 9.9
899 borna disease 9.9
900 prolactinoma 9.9
901 agoraphobia 9.9
902 juvenile rheumatoid arthritis 9.9
903 monoclonal gammopathy of uncertain significance 9.9
904 childhood leukemia 9.9
905 night blindness 9.9
906 autosomal dominant polycystic kidney disease 9.9
907 cleft lip 9.9
908 periodontal ehlers-danlos syndrome 9.9
909 acute graft versus host disease 9.9
910 glioma 9.9
911 prosthetic joint infection 9.9
912 sudden arrhythmia death syndrome 9.9
913 pituitary tumors 9.9
914 syncope 9.9
915 glial tumor 9.9
916 neonatal hypoxic and ischemic brain injury 9.9
917 apert syndrome 9.9
918 amyotrophic lateral sclerosis 1 9.9
919 angelman syndrome 9.9
920 pulmonary hemosiderosis 9.9
921 scoliosis, isolated 1 9.9
922 chromosome 2q35 duplication syndrome 9.9
923 ascites, chylous 9.9
924 nijmegen breakage syndrome 9.9
925 mucolipidosis ii alpha/beta 9.9
926 myxedema 9.9
927 ceroid lipofuscinosis, neuronal, 1 9.9
928 sjogren syndrome 9.9
929 cognitive function 1, social 9.9
930 mental retardation, skeletal dysplasia, and abducens palsy 9.9
931 retinitis pigmentosa 11 9.9
932 frontotemporal dementia 9.9
933 suppression of tumorigenicity 12 9.9
934 creatinine clearance quantitative trait locus 9.9
935 phobia, specific 9.9
936 pierson syndrome 9.9
937 body mass index quantitative trait locus 13 9.9
938 lipedema 9.9
939 glucocorticoid resistance, generalized 9.9
940 global developmental delay, lung cysts, overgrowth, and wilms tumor 9.9
941 neuronal ceroid-lipofuscinoses 9.9
942 colon adenoma 9.9
943 myelomeningocele 9.9
944 cerebral artery occlusion 9.9
945 open-angle glaucoma 9.9
946 borderline personality disorder 9.9
947 meconium aspiration syndrome 9.9
948 pulmonary edema 9.9
949 head and neck cancer 9.9
950 newborn respiratory distress syndrome 9.9
951 hyperinsulinemic hypoglycemia 9.9
952 tuberous sclerosis 9.9
953 renal artery atheroma 9.9
954 familial lipoprotein lipase deficiency 9.9
955 candidiasis 9.9
956 cystitis 9.9
957 heart septal defect 9.9
958 atrial heart septal defect 9.9
959 rectum adenocarcinoma 9.9
960 neonatal jaundice 9.9
961 pulmonary tuberculosis 9.9
962 thrombophlebitis 9.9
963 tricuspid valve insufficiency 9.9
964 hypertrichosis 9.9
965 intestinal benign neoplasm 9.9
966 uremia 9.9
967 premenstrual tension 9.9
968 osteochondrosis 9.9
969 skin melanoma 9.9
970 atrophic gastritis 9.9
971 central sleep apnea 9.9
972 intrinsic asthma 9.9
973 meningitis 9.9
974 pulmonary emphysema 9.9
975 toxoplasmosis 9.9
976 bap1 tumor predisposition syndrome 9.9
977 isolated gonadotropin-releasing hormone deficiency 9.9
978 sickle cell disease 9.9
979 brain tumor, childhood 9.9
980 carcinoid syndrome 9.9
981 bunion 9.9
982 acute liver failure 9.9
983 carotenemia 9.9
984 glucocorticoid-induced osteoporosis 9.8
985 eosinophilia-myalgia syndrome 9.8
986 coarctation of aorta 9.8
987 diabetes insipidus, neurohypophyseal 9.8
988 gilles de la tourette syndrome 9.8
989 glaucoma, primary open angle 9.8
990 marfan syndrome 9.8
991 melkersson-rosenthal syndrome 9.8
992 pick disease of brain 9.8
993 pilonidal sinus 9.8
994 pneumothorax, primary spontaneous 9.8
995 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.8
996 beta-aminoisobutyric aciduria 9.8
997 palmoplantar keratoderma and congenital alopecia 2 9.8
998 joubert syndrome 1 9.8
999 conotruncal heart malformations 9.8
1000 achalasia-addisonianism-alacrima syndrome 9.8
1001 renal glucosuria 9.8
1002 microphthalmia, isolated 1 9.8
1003 myeloperoxidase deficiency 9.8
1004 3mc syndrome 2 9.8
1005 muscular dystrophy, duchenne type 9.8
1006 androgen insensitivity, partial 9.8
1007 ventricular fibrillation, paroxysmal familial, 1 9.8
1008 late-onset retinal degeneration 9.8
1009 hypertensive nephropathy 9.8
1010 ovarian hyperstimulation syndrome 9.8
1011 aspirin resistance 9.8
1012 microphthalmia, syndromic 10 9.8
1013 acute promyelocytic leukemia 9.8
1014 lung cancer susceptibility 3 9.8
1015 hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome 9.8
1016 aspergillosis 9.8
1017 myelodysplastic syndrome 9.8
1018 dengue virus 9.8
1019 angiosarcoma 9.8
1020 congenital hypothyroidism 9.8
1021 familial adenomatous polyposis 9.8
1022 familial partial lipodystrophy 9.8
1023 brugada syndrome 9.8
1024 congenital generalized lipodystrophy 9.8
1025 polycystic liver disease 9.8
1026 hepatocellular adenoma 9.8
1027 follicular lymphoma 9.8
1028 3mc syndrome 9.8
1029 ptosis 9.8
1030 omphalocele 9.8
1031 anencephaly 9.8
1032 overactive bladder syndrome 9.8
1033 superior semicircular canal dehiscence 9.8
1034 meningoencephalitis 9.8
1035 hypospadias 9.8
1036 asphyxia neonatorum 9.8
1037 hydronephrosis 9.8
1038 disseminated intravascular coagulation 9.8
1039 pericardial effusion 9.8
1040 myopia 9.8
1041 pica disease 9.8
1042 dengue hemorrhagic fever 9.8
1043 bile reflux 9.8
1044 vulva cancer 9.8
1045 hypochondriasis 9.8
1046 kwashiorkor 9.8
1047 premature ejaculation 9.8
1048 panniculitis 9.8
1049 urticaria 9.8
1050 pneumothorax 9.8
1051 lateral sclerosis 9.8
1052 sensory peripheral neuropathy 9.8
1053 pancreas disease 9.8
1054 papilloma 9.8
1055 glycogen storage disease 9.8
1056 acquired polycythemia 9.8
1057 cystic kidney disease 9.8
1058 glioblastoma 9.8
1059 gastric dilatation 9.8
1060 placental insufficiency 9.8
1061 mediastinal lipomatosis 9.8
1062 folliculitis 9.8
1063 neurotic disorder 9.8
1064 adjustment disorder 9.8
1065 colonic disease 9.8
1066 adult acute lymphocytic leukemia 9.8
1067 aortic valve insufficiency 9.8
1068 lymphopenia 9.8
1069 inflammatory breast carcinoma 9.8
1070 mediastinitis 9.8
1071 herpes simplex 9.8
1072 status asthmaticus 9.8
1073 dextrocardia 9.8
1074 disorders of gnas inactivation 9.8
1075 cervical intraepithelial neoplasia 9.8
1076 encephalocele 9.8
1077 galactorrhoea-hyperprolactinaemia 9.8
1078 gigantomastia 9.8
1079 mast cell activation syndrome 9.8
1080 pfeiffer syndrome 9.8
1081 aortic valve disease 1 9.8
1082 lynch syndrome 1 9.8
1083 hepatic adenomas, familial 9.8
1084 meralgia paraesthetica, familial 9.8
1085 myotonia congenita, autosomal dominant 9.8
1086 preeclampsia/eclampsia 1 9.8
1087 suppressor of tumorigenicity 3 9.8
1088 renal hypodysplasia/aplasia 1 9.8
1089 calcification of joints and arteries 9.8
1090 corpus callosum, agenesis of 9.8
1091 enterocolitis 9.8
1092 epiphyseal dysplasia, multiple, 4 9.8
1093 factor vii deficiency 9.8
1094 autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia 9.8
1095 jawad syndrome 9.8
1096 mucolipidosis iv 9.8
1097 multicentric osteolysis, nodulosis, and arthropathy 9.8
1098 respiratory distress syndrome in premature infants 9.8
1099 sudden infant death syndrome 9.8
1100 wernicke-korsakoff syndrome 9.8
1101 wilson disease 9.8
1102 fragile x syndrome 9.8
1103 multiple congenital anomalies-neurodevelopmental syndrome, x-linked 9.8
1104 night blindness, congenital stationary, type 1a 9.8
1105 paine syndrome 9.8
1106 type 1 diabetes mellitus 5 9.8
1107 autoimmune lymphoproliferative syndrome 9.8
1108 ossification of the posterior longitudinal ligament of spine 9.8
1109 pseudohypoparathyroidism, type ib 9.8
1110 glaucoma 1, open angle, f 9.8
1111 immunodeficiency with hyper-igm, type 3 9.8
1112 mammographic density 9.8
1113 platelet glycoprotein iv deficiency 9.8
1114 carotid intimal medial thickness 2 9.8
1115 aplastic anemia 9.8
1116 drug metabolism, poor, cyp2c19-related 9.8
1117 asthma-related traits 4 9.8
1118 chromosome 22q11.2 deletion syndrome, distal 9.8
1119 cholangitis, primary sclerosing 9.8
1120 small cell carcinoma 9.8
1121 androgenic alopecia 9.8
1122 oppositional defiant disorder 9.8
1123 colorectal adenocarcinoma 9.8
1124 oral squamous cell carcinoma 9.8
1125 withdrawal disorder 9.8
1126 stuttering 9.8
1127 chromosome 1p36 deletion syndrome 9.8
1128 left ventricular noncompaction 9.8
1129 familial glucocorticoid deficiency 9.8
1130 multisystem inflammatory syndrome in children 9.8
1131 complete androgen insensitivity syndrome 9.8
1132 chronic asthma 9.8
1133 exercise-induced bronchoconstriction 9.8
1134 serum amyloid a amyloidosis 9.8
1135 migraine with aura 9.8
1136 osteonecrosis 9.8
1137 otorrhea 9.8
1138 cardia cancer 9.8
1139 lactose intolerance 9.8
1140 mastitis 9.8
1141 cholecystolithiasis 9.8
1142 tetanus 9.8
1143 penile cancer 9.8
1144 penile benign neoplasm 9.8
1145 oligohydramnios 9.8
1146 gender incongruence 9.8
1147 multiple epiphyseal dysplasia 9.8
1148 diabetic polyneuropathy 9.8
1149 bacteriuria 9.8
1150 sclerosing cholangitis 9.8
1151 niemann-pick disease 9.8
1152 hypersensitivity reaction type iii disease 9.8
1153 testicular disease 9.8
1154 hemangioma 9.8
1155 opiate dependence 9.8
1156 tic disorder 9.8
1157 central nervous system disease 9.8
1158 fibrosarcoma 9.8
1159 liposarcoma 9.8
1160 bacterial vaginosis 9.8
1161 histiocytosis 9.8
1162 pleural empyema 9.8
1163 lynch syndrome 9.8
1164 lymphocele 9.8
1165 biliary tract cancer 9.8
1166 poliomyelitis 9.8
1167 dystonia 9.8
1168 conjunctivitis 9.8
1169 prion disease 9.8
1170 connective tissue disease 9.8
1171 adrenal adenoma 9.8
1172 polyhydramnios 9.8
1173 measles 9.8
1174 leishmaniasis 9.8
1175 encephalitis 9.8
1176 necrotizing fasciitis 9.8
1177 vesicoureteral reflux 9.8
1178 hemorrhoid 9.8
1179 multiple epiphyseal dysplasia, recessive 9.8
1180 catastrophic antiphospholipid syndrome 9.8
1181 combined pituitary hormone deficiencies, genetic forms 9.8
1182 cryopyrin-associated periodic syndrome 9.8
1183 epilepsy with myoclonic-atonic seizures 9.8
1184 neural crest tumor 9.8
1185 pediatric multiple sclerosis 9.8
1186 single ventricular heart 9.8
1187 tuberculous meningitis 9.8
1188 age-related hearing loss 9.8
1189 cerebrofacial arteriovenous metameric syndrome 9.8
1190 inflammatory myopathy with abundant macrophages 9.8
1191 germ cell tumor 9.8
1192 acute sensory ataxic neuropathy 9.8
1193 malignant tumor of penis 9.8
1194 chronic bilirubin encephalopathy 9.8
1195 maternal uniparental disomy 9.8
1196 thyroid tumor 9.8
1197 abducens palsy 9.7
1198 atrial standstill 1 9.7
1199 behcet syndrome 9.7
1200 progressive familial heart block, type ia 9.7
1201 cataract 6, multiple types 9.7
1202 dilution, pigmentary 9.7
1203 exostoses, multiple, type i 9.7
1204 lymphoma, mucosa-associated lymphoid type 9.7
1205 hand skill, relative 9.7
1206 hypertelorism 9.7
1207 kaposi sarcoma 9.7
1208 legg-calve-perthes disease 9.7
1209 cowden syndrome 1 9.7
1210 myotonic dystrophy 1 9.7
1211 polykaryocytosis inducer 9.7
1212 mccune-albright syndrome 9.7
1213 digeorge syndrome 9.7
1214 thyroid cancer, nonmedullary, 2 9.7
1215 thyroid hormone resistance, generalized, autosomal dominant 9.7
1216 cenani-lenz syndactyly syndrome 9.7
1217 wolfram syndrome 1 9.7
1218 schopf-schulz-passarge syndrome 9.7
1219 galactorrhea 9.7
1220 hemochromatosis, type 1 9.7
1221 osteogenic sarcoma 9.7
1222 hypothyroidism, congenital, nongoitrous, 4 9.7
1223 squamous cell carcinoma, head and neck 9.7
1224 otopalatodigital syndrome, type ii 9.7
1225 otopalatodigital syndrome, type i 9.7
1226 pyruvate dehydrogenase e1-alpha deficiency 9.7
1227 kearns-sayre syndrome 9.7
1228 parkinson disease 2, autosomal recessive juvenile 9.7
1229 type 2 diabetes mellitus 2 9.7
1230 short stature, auditory canal atresia, mandibular hypoplasia, and skeletal abnormalities 9.7
1231 acromesomelic dysplasia 1 9.7
1232 chudley-mccullough syndrome 9.7
1233 dermatitis, atopic, 2 9.7
1234 myopathy, myosin storage, autosomal dominant 9.7
1235 transposition of the great arteries, dextro-looped 9.7
1236 esophagitis, eosinophilic, 1 9.7
1237 congenital lipomatous overgrowth, vascular malformations, and epidermal nevi 9.7
1238 acetyl-coa acetyltransferase-2 deficiency 9.7
1239 fanconi anemia, complementation group l 9.7
1240 accelerated tumor formation 9.7
1241 peripartum cardiomyopathy 9.7
1242 immunodeficiency 14a, autosomal dominant 9.7
1243 pachyonychia congenita 3 9.7
1244 iron overload 9.7
1245 bacterial sepsis 9.7
1246 hypophosphatemia 9.7
1247 asperger syndrome 9.7
1248 hyperphosphatemia 9.7
1249 paraganglioma 9.7
1250 cone dystrophy 9.7
1251 infective endocarditis 9.7
1252 microscopic colitis 9.7
1253 isolated growth hormone deficiency 9.7
1254 human cytomegalovirus infection 9.7
1255 progressive familial heart block 9.7
1256 immunodeficiency 14 9.7
1257 keratoconus 9.7
1258 dry eye syndrome 9.7
1259 osteomyelitis 9.7
1260 pinta disease 9.7
1261 endocarditis 9.7
1262 viral pneumonia 9.7
1263 microinvasive gastric cancer 9.7
1264 microphthalmia 9.7
1265 thrombotic thrombocytopenic purpura 9.7
1266 amnestic disorder 9.7
1267 multiple personality disorder 9.7
1268 antisocial personality disorder 9.7
1269 hemiplegia 9.7
1270 brucellosis 9.7
1271 pertussis 9.7
1272 rabies 9.7
1273 mitral valve insufficiency 9.7
1274 cauda equina syndrome 9.7
1275 lyme disease 9.7
1276 hepatorenal syndrome 9.7
1277 chagas disease 9.7
1278 paranoid schizophrenia 9.7
1279 dysentery 9.7
1280 pancytopenia 9.7
1281 acute kidney tubular necrosis 9.7
1282 leiomyoma 9.7
1283 carotid stenosis 9.7
1284 hepatic encephalopathy 9.7
1285 glanders 9.7
1286 somatization disorder 9.7
1287 renal tubular acidosis 9.7
1288 cholera 9.7
1289 avoidant personality disorder 9.7
1290 angioedema 9.7
1291 ventricular septal defect 9.7
1292 ichthyosis 9.7
1293 pericarditis 9.7
1294 calcinosis 9.7
1295 atypical teratoid rhabdoid tumor 9.7
1296 gastroenteritis 9.7
1297 relapsing-remitting multiple sclerosis 9.7
1298 larynx cancer 9.7
1299 laryngeal benign neoplasm 9.7
1300 myoma 9.7
1301 long qt syndrome 9.7
1302 hemoglobin c disease 9.7
1303 bronchiolitis 9.7
1304 serous cystadenocarcinoma 9.7
1305 cutis laxa 9.7
1306 demyelinating disease 9.7
1307 thymoma 9.7
1308 carotid artery disease 9.7
1309 duodenal obstruction 9.7
1310 eosinophilic gastroenteritis 9.7
1311 skin angiosarcoma 9.7
1312 ganglioneuroma 9.7
1313 intrahepatic cholangiocarcinoma 9.7
1314 eosinophilic pneumonia 9.7
1315 active peptic ulcer disease 9.7
1316 stomach disease 9.7
1317 herpes zoster 9.7
1318 duodenitis 9.7
1319 vasculitis 9.7
1320 chickenpox 9.7
1321 perinatal necrotizing enterocolitis 9.7
1322 bacterial pneumonia 9.7
1323 dermatophytosis 9.7
1324 hepatopulmonary syndrome 9.7
1325 ocular hypertension 9.7
1326 lipid storage disease 9.7
1327 plantar fasciitis 9.7
1328 kidney hypertrophy 9.7
1329 biliary tract disease 9.7
1330 hypoplastic left heart syndrome 9.7
1331 broken heart syndrome 9.7
1332 cataract-glaucoma 9.7
1333 chronic graft versus host disease 9.7
1334 cluster headache 9.7
1335 heparin-induced thrombocytopenia 9.7
1336 lip and oral cavity cancer 9.7
1337 pituitary stalk interruption syndrome 9.7
1338 splenomegaly 9.7
1339 sudden sensorineural hearing loss 9.7
1340 dysautonomia 9.7
1341 postural tachycardia syndrome 9.7
1342 b-cell non-hodgkin lymphoma 9.7
1343 cleft lip/palate 9.7
1344 differentiated thyroid carcinoma 9.7
1345 jeavons syndrome 9.7
1346 inherited cancer-predisposing syndrome 9.7
1347 progressive cone dystrophy 9.7
1348 pouchitis 9.7
1349 benign idiopathic neonatal seizures 9.7
1350 primary lymphedema 9.7
1351 mitochondrial disease 9.7
1352 upper tract urothelial carcinoma 9.7
1353 cerebral amyloid angiopathy, cst3-related 9.6
1354 arthrogryposis, distal, type 1a 9.6
1355 cerebral cavernous malformations 9.6
1356 coloboma of macula 9.6
1357 corneal dystrophy, epithelial basement membrane 9.6
1358 cornelia de lange syndrome 1 9.6
1359 creutzfeldt-jakob disease 9.6
1360 major affective disorder 1 9.6
1361 maturity-onset diabetes of the young, type 2 9.6
1362 type 1 diabetes mellitus 2 9.6
1363 earlobe crease 9.6
1364 beckwith-wiedemann syndrome 9.6
1365 lateral meningocele syndrome 9.6
1366 erythermalgia, primary 9.6
1367 hemifacial hyperplasia 9.6
1368 coffin-siris syndrome 1 9.6
1369 goiter, multinodular 1, with or without sertoli-leydig cell tumors 9.6
1370 guillain-barre syndrome, familial 9.6
1371 developmental dysplasia of the hip 1 9.6
1372 macroglossia 9.6
1373 facioscapulohumeral muscular dystrophy 1 9.6
1374 oculocerebrocutaneous syndrome 9.6
1375 spinocerebellar ataxia 1 9.6
1376 optic nerve hypoplasia, bilateral 9.6
1377 paroxysmal extreme pain disorder 9.6
1378 papillomatosis, confluent and reticulated 9.6
1379 familial adenomatous polyposis 1 9.6
1380 interstitial lung disease 2 9.6
1381 raynaud disease 9.6
1382 storm syndrome 9.6
1383 thrombophilia due to activated protein c resistance 9.6
1384 trigeminal neuralgia 9.6
1385 velocardiofacial syndrome 9.6
1386 wolf-hirschhorn syndrome 9.6
1387 acrocallosal syndrome 9.6
1388 acth deficiency, isolated 9.6
1389 anus, imperforate 9.6
1390 arthrogryposis, renal dysfunction, and cholestasis 1 9.6
1391 c syndrome 9.6
1392 gordon holmes syndrome 9.6
1393 persistent hyperplastic primary vitreous, autosomal recessive 9.6
1394 enterokinase deficiency 9.6
1395 fanconi anemia, complementation group a 9.6
1396 multiple acyl-coa dehydrogenase deficiency 9.6
1397 glycogen storage disease ia 9.6
1398 glycogen storage disease v 9.6
1399 hypoadrenocorticism, familial 9.6
1400 hypoparathyroidism-retardation-dysmorphism syndrome 9.6
1401 erythrocyte lactate transporter defect 9.6
1402 lecithin:cholesterol acyltransferase deficiency 9.6
1403 chylomicron retention disease 9.6
1404 meckel syndrome, type 1 9.6
1405 familial mediterranean fever 9.6
1406 melanosis, neurocutaneous 9.6
1407 biotinidase deficiency 9.6
1408 multiple pterygium syndrome, lethal type 9.6
1409 spinal muscular atrophy, type i 9.6
1410 myasthenia gravis 9.6
1411 polycythemia vera 9.6
1412 pseudovaginal perineoscrotal hypospadias 9.6
1413 enhanced s-cone syndrome 9.6
1414 sclerosteosis 1 9.6
1415 short syndrome 9.6
1416 spastic ataxia, charlevoix-saguenay type 9.6
1417 spinocerebellar ataxia, autosomal recessive 3 9.6
1418 asplenia, isolated congenital 9.6
1419 canavan disease 9.6
1420 testicular germ cell tumor 9.6
1421 muscular dystrophy, becker type 9.6
1422 brunner syndrome 9.6
1423 bone mineral density quantitative trait locus 18 9.6
1424 hypophosphatemic rickets, x-linked dominant 9.6
1425 intellectual disability-hypotonic facies syndrome, x-linked, 1 9.6
1426 linear skin defects with multiple congenital anomalies 1 9.6
1427 rett syndrome 9.6
1428 diabetes and deafness, maternally inherited 9.6
1429 cleft palate, cardiac defect, genital anomalies, and ectrodactyly 9.6
1430 maturity-onset diabetes of the young, type 3 9.6
1431 neurofibromatosis-noonan syndrome 9.6
1432 athabaskan brainstem dysgenesis syndrome 9.6
1433 astigmatism 9.6
1434 huntington disease-like 1 9.6
1435 hemophagocytic lymphohistiocytosis, familial, 2 9.6
1436 urinary tract infections, recurrent 9.6
1437 orthostatic intolerance 9.6
1438 langerhans cell histiocytosis 9.6
1439 basal cell carcinoma 1 9.6
1440 anisomastia 9.6
1441 narcolepsy 2 9.6
1442 nephrolithiasis, uric acid 9.6
1443 atrioventricular septal defect 9.6
1444 alveolar soft part sarcoma 9.6
1445 parkinson disease 7, autosomal recessive early-onset 9.6
1446 scheie syndrome 9.6
1447 asthma-related traits 1 9.6
1448 niemann-pick disease, type c2 9.6
1449 chromosome 1p36 deletion syndrome, distal 9.6
1450 asthma-related traits 2 9.6
1451 colorectal cancer 1 9.6
1452 west nile virus 9.6
1453 coronary heart disease 7 9.6
1454 malaria 9.6
1455 cavitary optic disc anomalies 9.6
1456 fontaine progeroid syndrome 9.6
1457 major affective disorder 7 9.6
1458 antithrombin iii deficiency 9.6
1459 plasminogen activator inhibitor-1 deficiency 9.6
1460 alpha-1-antitrypsin deficiency 9.6
1461 macrostomia, isolated 9.6
1462 adrenal insufficiency, congenital, with 46,xy sex reversal, partial or complete 9.6
1463 complement component 3 deficiency, autosomal recessive 9.6
1464 episodic ataxia, type 5 9.6
1465 brittle cornea syndrome 2 9.6
1466 glycerol quantitative trait locus 9.6
1467 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 9.6
1468 hyperproinsulinemia 9.6
1469 immunodeficiency 40 9.6
1470 seizures, scoliosis, and macrocephaly/microcephaly syndrome 9.6
1471 renal hypodysplasia/aplasia 3 9.6
1472 encephalitis/encephalopathy, mild, with reversible myelin vacuolization 9.6
1473 neuropathy, congenital hypomyelinating, 2 9.6
1474 fetal akinesia deformation sequence 3 9.6
1475 diarrhea 11, malabsorptive, congenital 9.6
1476 mandibuloacral dysplasia progeroid syndrome 9.6
1477 craniotubular dysplasia, ikegawa type 9.6
1478 tumor predisposition syndrome 2 9.6
1479 hypertrophic scars 9.6
1480 chronic ulcer of skin 9.6
1481 tendinitis 9.6
1482 twin-to-twin transfusion syndrome 9.6
1483 chikungunya 9.6
1484 orofacial cleft 9.6
1485 distal arthrogryposis 9.6
1486 fetal alcohol syndrome 9.6
1487 spastic cerebral palsy 9.6
1488 rheumatic heart disease 9.6
1489 pervasive developmental disorder 9.6
1490 body dysmorphic disorder 9.6
1491 juvenile absence epilepsy 9.6
1492 ileitis 9.6
1493 ileocolitis 9.6
1494 sclerosteosis 9.6
1495 primary pigmented nodular adrenocortical disease 9.6
1496 lung abscess 9.6
1497 anal fistula 9.6
1498 ectopic pregnancy 9.6
1499 epithelial basement membrane dystrophy 9.6
1500 drug allergy 9.6
1501 salmonellosis 9.6
1502 intestinal pseudo-obstruction 9.6
1503 lymphoblastic lymphoma 9.6
1504 cakut 9.6
1505 mixed sleep apnea 9.6
1506 middle east respiratory syndrome 9.6
1507 chronic urticaria 9.6
1508 occupational asthma 9.6
1509 nonobstructive coronary artery disease 9.6
1510 graves ophthalmopathy 9.6
1511 dopamine beta-hydroxylase deficiency 9.6
1512 trichothiodystrophy 9.6
1513 combined immunodeficiency 9.6
1514 pelvic inflammatory disease 9.6
1515 endometrial disease 9.6
1516 cysticercosis 9.6
1517 xerophthalmia 9.6
1518 left bundle branch hemiblock 9.6
1519 siderosis 9.6
1520 acute pericementitis 9.6
1521 interstitial nephritis 9.6
1522 chronic pyelonephritis 9.6
1523 lipoid nephrosis 9.6
1524 prostatic hypertrophy 9.6
1525 esophageal varix 9.6
1526 allergic conjunctivitis 9.6
1527 spondyloarthropathy 9.6
1528 appendiceal neoplasm 9.6
1529 erysipelas 9.6
1530 megacolon 9.6
1531 constrictive pericarditis 9.6
1532 rumination disorder 9.6
1533 hypertensive retinopathy 9.6
1534 neonatal diabetes 9.6
1535 cornelia de lange syndrome 9.6
1536 choledocholithiasis 9.6
1537 coronary thrombosis 9.6
1538 mononeuropathy 9.6
1539 nutritional optic neuropathy 9.6
1540 optic neuritis 9.6
1541 hemosiderosis 9.6
1542 neurogenic bladder 9.6
1543 marasmus 9.6
1544 pathological gambling 9.6
1545 hepatitis a 9.6
1546 nephronophthisis 9.6
1547 telangiectasis 9.6
1548 cerebral atherosclerosis 9.6
1549 guillain-barre syndrome 9.6
1550 endomyocardial fibrosis 9.6
1551 hellp syndrome 9.6
1552 uveitis 9.6
1553 megaesophagus 9.6
1554 background diabetic retinopathy 9.6
1555 diverticulitis of colon 9.6
1556 exocrine pancreatic insufficiency 9.6
1557 megaloblastic anemia 9.6
1558 obstructive jaundice 9.6
1559 biliary atresia 9.6
1560 patent foramen ovale 9.6
1561 anodontia 9.6
1562 schistosomiasis 9.6
1563 plasmodium falciparum malaria 9.6
1564 anterior uveitis 9.6
1565 epicondylitis 9.6
1566 ureterolithiasis 9.6
1567 frozen shoulder 9.6
1568 oligospermia 9.6
1569 pulmonary valve insufficiency 9.6
1570 pyuria 9.6
1571 rheumatic fever 9.6
1572 thrombocytopenia due to platelet alloimmunization 9.6
1573 endocrine gland cancer 9.6
1574 retinal vein occlusion 9.6
1575 ocular melanoma 9.6
1576 mitral valve stenosis 9.6
1577 neuritis 9.6
1578 childhood absence epilepsy 9.6
1579 bone cancer 9.6
1580 dysostosis 9.6
1581 myeloproliferative neoplasm 9.6
1582 craniosynostosis 9.6
1583 macrocytic anemia 9.6
1584 post-thrombotic syndrome 9.6
1585 renal artery disease 9.6
1586 basal cell carcinoma 9.6
1587 agammaglobulinemia 9.6
1588 cystadenoma 9.6
1589 transitional cell carcinoma 9.6
1590 membranoproliferative glomerulonephritis 9.6
1591 antiphospholipid syndrome 9.6
1592 testicular cancer 9.6
1593 multiple endocrine neoplasia 9.6
1594 mucinoses 9.6
1595 neurilemmoma 9.6
1596 syringomyelia 9.6
1597 germinoma 9.6
1598 teratoma 9.6
1599 bone inflammation disease 9.6
1600 laryngitis 9.6
1601 necrobiosis lipoidica 9.6
1602 male reproductive organ cancer 9.6
1603 restrictive cardiomyopathy 9.6
1604 ganglioneuroblastoma 9.6
1605 dyslexia 9.6
1606 holoprosencephaly 9.6
1607 placenta accreta 9.6
1608 pilocytic astrocytoma 9.6
1609 essential tremor 9.6
1610 ovarian cyst 9.6
1611 urinary tract obstruction 9.6
1612 epithelial-myoepithelial carcinoma 9.6
1613 penis squamous cell carcinoma 9.6
1614 acute pyelonephritis 9.6
1615 thyroid hyalinizing trabecular adenoma 9.6
1616 lymphatic system disease 9.6
1617 gallbladder melanoma 9.6
1618 complement component 3 deficiency 9.6
1619 brachial plexus lesion 9.6
1620 cyclothymic disorder 9.6
1621 pellagra 9.6
1622 actinomycosis 9.6
1623 monocytic leukemia 9.6
1624 oropharynx cancer 9.6
1625 subacute delirium 9.6
1626 neurofibromatosis 9.6
1627 gas gangrene 9.6
1628 homocystinuria 9.6
1629 bronchiectasis 9.6
1630 complete plasminogen activator inhibitor 1 deficiency 9.6
1631 glucose transporter type 1 deficiency syndrome 9.6
1632 hypermobile ehlers-danlos syndrome 9.6
1633 notch3-related lateral meningocele syndrome 9.6
1634 type ii collagen disorders 9.6
1635 attenuated familial adenomatous polyposis 9.6
1636 autoimmune encephalitis 9.6
1637 carcinoma showing thymus-like differentiation 9.6
1638 chromosome 19q duplication 9.6
1639 chronic thromboembolic pulmonary hypertension 9.6
1640 diencephalic syndrome 9.6
1641 febrile infection-related epilepsy syndrome 9.6
1642 glucagonoma 9.6
1643 mal de debarquement syndrome 9.6
1644 penis agenesis 9.6
1645 talipes equinovarus 9.6
1646 aldosterone-producing adenoma 9.6
1647 grn-related frontotemporal lobar degeneration 9.6
1648 atrial fibrillation and stroke 9.6
1649 febrile seizures 9.6
1650 foot drop 9.6
1651 hypertonia 9.6
1652 spasticity 9.6
1653 posttransplant acute limbic encephalitis 9.6
1654 interatrial communication 9.6
1655 periodic paralysis 9.6
1656 virus-associated trichodysplasia spinulosa 9.6
1657 severe early-childhood-onset retinal dystrophy 9.6
1658 idiopathic nephrotic syndrome 9.6
1659 arterial thoracic outlet syndrome 9.6
1660 chronic enteropathy associated with slco2a1 gene 9.6
1661 necrotizing soft tissue infection 9.6
1662 resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha 9.6
1663 non-specific syndromic intellectual disability 9.6
1664 other metabolic disease 9.6
1665 non-functioning pituitary adenoma 9.6
1666 pigmentation anomaly of the skin 9.6
1667 mild hyperphenylalaninemia 9.6
1668 infectious encephalitis 9.6
1669 juvenile nephronophthisis 9.6
1670 epiblepharon 9.6
1671 gastroenteropancreatic neuroendocrine neoplasm 9.6
1672 acth-independent cushing syndrome 9.6
1673 idiopathic syringomyelia 9.6
1674 twin anemia-polycythemia sequence 9.6
1675 selective intrauterine growth restriction 9.6
1676 tietz albinism-deafness syndrome 9.5
1677 alzheimer disease 2 9.5
1678 amyloidosis, familial visceral 9.5
1679 arteriovenous malformations of the brain 9.5
1680 machado-joseph disease 9.5
1681 leukemia, chronic lymphocytic 2 9.5
1682 cardiomyopathy, familial hypertrophic, 2 9.5
1683 sotos syndrome 9.5
1684 cerebrocostomandibular syndrome 9.5
1685 chorea, benign hereditary 9.5
1686 colchicine resistance 9.5
1687 coloboma, ocular, autosomal dominant 9.5
1688 spondylocostal dysostosis 5 9.5
1689 optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy 9.5
1690 dens evaginatus 9.5
1691 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 9.5
1692 dentin dysplasia, type i 9.5
1693 ehlers-danlos syndrome, arthrochalasia type, 1 9.5
1694 camurati-engelmann disease 9.5
1695 epidermolysis bullosa dystrophica, autosomal dominant 9.5
1696 pilomatrixoma 9.5
1697 exostoses, multiple, type ii 9.5
1698 renal cysts and diabetes syndrome 9.5
1699 hair morphology 2 9.5
1700 hawkinsinuria 9.5
1701 hirschsprung disease 1 9.5
1702 huntington disease 9.5
1703 hyperalphalipoproteinemia 1 9.5
1704 gilbert syndrome 9.5
1705 orthostatic hypotensive disorder, streeten type 9.5
1706 hyperlipoproteinemia, type v 9.5
1707 chromosome 18p deletion syndrome 9.5
1708 bart-pumphrey syndrome 9.5
1709 laryngeal abductor paralysis 9.5
1710 laryngomalacia 9.5
1711 lentigines 9.5
1712 leukemia, acute monocytic 9.5
1713 lichen sclerosus et atrophicus 9.5
1714 li-fraumeni syndrome 9.5
1715 thyroid carcinoma, familial medullary 9.5
1716 medulloblastoma 9.5
1717 intellectual developmental disorder, autosomal dominant 1 9.5
1718 metaphyseal chondrodysplasia, schmid type 9.5
1719 moebius syndrome 9.5
1720 chromosome 9p deletion syndrome 9.5
1721 nondisjunction 9.5
1722 episodic ataxia, type 1 9.5
1723 neuropathy, hereditary, with liability to pressure palsies 9.5
1724 noonan syndrome 1 9.5
1725 schilbach-rott syndrome 9.5
1726 pancreas, dorsal, agenesis of 9.5
1727 paragangliomas 1 9.5
1728 char syndrome 9.5
1729 andersen cardiodysrhythmic periodic paralysis 9.5
1730 hypokalemic periodic paralysis, type 1 9.5
1731 platelet membrane fluidity 9.5
1732 tubulointerstitial kidney disease, autosomal dominant, 2 9.5
1733 polydactyly, postaxial, type a1 9.5
1734 polydactyly, preaxial i 9.5
1735 polydactyly, preaxial iv 9.5
1736 precocious puberty, male-limited 9.5
1737 protoporphyria, erythropoietic, 1 9.5
1738 rubinstein-taybi syndrome 1 9.5
1739 scalp-ear-nipple syndrome 9.5
1740 spinocerebellar ataxia 2 9.5
1741 spondylosis, cervical 9.5
1742 telecanthus 9.5
1743 temporal arteritis 9.5
1744 thrombocythemia 1 9.5
1745 thrombocytopenic purpura, autoimmune 9.5
1746 trichorhinophalangeal syndrome, type i 9.5
1747 muckle-wells syndrome 9.5
1748 uterine anomalies 9.5
1749 vertigo, benign recurrent 9.5
1750 vitiligo-associated multiple autoimmune disease susceptibility 6 9.5
1751 abetalipoproteinemia 9.5
1752 acyl-coa dehydrogenase, short-chain, deficiency of 9.5
1753 acyl-coa dehydrogenase, very long-chain, deficiency of 9.5
1754 afibrinogenemia, congenital 9.5
1755 albinism, oculocutaneous, type ii 9.5
1756 albinism, oculocutaneous, type iii 9.5
1757 ceroid lipofuscinosis, neuronal, 3 9.5
1758 anemia, sideroblastic, 2, pyridoxine-refractory 9.5
1759 nail disorder, nonsyndromic congenital, 4 9.5
1760 takayasu arteritis 9.5
1761 argininemia 9.5
1762 arterial tortuosity syndrome 9.5
1763 asthma, nasal polyps, and aspirin intolerance 9.5
1764 ataxia-telangiectasia 9.5
1765 ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia 9.5
1766 bloom syndrome 9.5
1767 elsahy-waters syndrome 9.5
1768 buerger disease 9.5
1769 cardiomyopathy, dilated, with hypergonadotropic hypogonadism 9.5
1770 carnitine deficiency, systemic primary 9.5
1771 martsolf syndrome 1 9.5
1772 chondrodysplasia punctata syndrome 9.5
1773 boucher-neuhauser syndrome 9.5
1774 costello syndrome 9.5
1775 crigler-najjar syndrome, type i 9.5
1776 mitochondrial complex iv deficiency, nuclear type 1 9.5
1777 diastrophic dysplasia 9.5
1778 duodenal atresia 9.5
1779 ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive 9.5
1780 ehlers-danlos syndrome, kyphoscoliotic type, 1 9.5
1781 fanconi anemia, complementation group c 9.5
1782 fanconi-bickel syndrome 9.5
1783 friedreich ataxia 9.5
1784 fructose utilization 9.5
1785 fructosuria, essential 9.5
1786 gaucher disease, type i 9.5
1787 gaucher disease, type iii 9.5
1788 3-hydroxyacyl-coa dehydrogenase deficiency 9.5
1789 glutaric acidemia i 9.5
1790 glycogen storage disease iv 9.5
1791 hemolytic uremic syndrome, atypical 1 9.5
1792 holoprosencephaly 1 9.5
1793 homocarnosinosis 9.5
1794 homocystinuria due to cystathionine beta-synthase deficiency 9.5
1795 hydrocephalus due to congenital stenosis of aqueduct of sylvius 9.5
1796 hyperparathyroidism, neonatal severe 9.5
1797 hypoplastic left heart syndrome 1 9.5
1798 jejunal atresia 9.5
1799 arima syndrome 9.5
1800 succinyl-coa:3-oxoacid-coa transferase deficiency 9.5
1801 epidermolysis bullosa, junctional 2c, laryngoonychocutaneous 9.5
1802 leprosy 3 9.5
1803 3-hydroxy-3-methylglutaryl-coa lyase deficiency 9.5
1804 metaphyseal dysplasia, spahr type 9.5
1805 methane production 9.5
1806 methylmalonic aciduria, cbla type 9.5
1807 galloway-mowat syndrome 1 9.5
1808 moyamoya disease 1 9.5
1809 mucopolysaccharidosis, type vi 9.5
1810 spinal muscular atrophy, type iii 9.5
1811 myelofibrosis 9.5
1812 epilepsy, myoclonic juvenile 9.5
1813 carnitine palmitoyltransferase i deficiency 9.5
1814 leigh syndrome 9.5
1815 osteogenesis imperfecta, type iii 9.5
1816 osteoporosis, juvenile 9.5
1817 hyperoxaluria, primary, type i 9.5
1818 hyperoxaluria, primary, type ii 9.5
1819 pancreatic agenesis 1 9.5
1820 isolated growth hormone deficiency, type ia 9.5
1821 polycystic kidney disease 4 with or without polycystic liver disease 9.5
1822 short-rib thoracic dysplasia 6 with or without polydactyly 9.5
1823 bartsocas-papas syndrome 1 9.5
1824 multiple pterygium syndrome, escobar variant 9.5
1825 pulmonary hypoplasia, primary 9.5
1826 pulmonic stenosis 9.5
1827 pycnodysostosis 9.5
1828 lipodystrophy, congenital generalized, type 2 9.5
1829 sodium-potassium-atpase activity of red cell 9.5
1830 spermatogenic failure 4 9.5
1831 succinic semialdehyde dehydrogenase deficiency 9.5
1832 taurodontism 9.5
1833 chanarin-dorfman syndrome 9.5
1834 spastic paraplegia 20, autosomal recessive 9.5
1835 ulna and fibula, absence of, with severe limb deficiency 9.5
1836 werner syndrome 9.5
1837 coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation, and ear anomalies syndrome 9.5
1838 intellectual developmental disorder, x-linked, syndromic 13 9.5
1839 intellectual developmental disorder, x-linked, syndromic 7 9.5
1840 testicular germ cell tumor 1 9.5
1841 ectodermal dysplasia and immunodeficiency 1 9.5
1842 osteopathia striata with cranial sclerosis 9.5
1843 allan-herndon-dudley syndrome 9.5
1844 immunodeficiency 33 9.5
1845 anemia, sideroblastic, 1 9.5
1846 agammaglobulinemia, x-linked 9.5
1847 ogden syndrome 9.5
1848 cornelia de lange syndrome 5 9.5
1849 hypothyroidism, central, with testicular enlargement 9.5
1850 choroideremia 9.5
1851 coffin-lowry syndrome 9.5
1852 deafness, x-linked 2 9.5
1853 ectodermal dysplasia 1, hypohidrotic, x-linked 9.5
1854 genitourinary tract anomalies 9.5
1855 glycerol kinase deficiency 9.5
1856 ichthyosis, x-linked 9.5
1857 lymphoproliferative syndrome, x-linked, 1 9.5
1858 leber hereditary optic neuropathy, modifier of 9.5
1859 major affective disorder 2 9.5
1860 mental retardation with optic atrophy, deafness, and seizures 9.5
1861 intellectual developmental disorder, x-linked, syndromic, turner type 9.5
1862 emery-dreifuss muscular dystrophy 1, x-linked 9.5
1863 premature ovarian failure 1 9.5
1864 pelizaeus-merzbacher disease 9.5
1865 myoclonic epilepsy associated with ragged-red fibers 9.5
1866 oncocytoma 9.5
1867 gonadal agenesis 9.5
1868 abcd syndrome 9.5
1869 epilepsy, idiopathic generalized 9.5
1870 fryns microphthalmia syndrome 9.5
1871 hypocalcemia, autosomal dominant 1 9.5
1872 amelia, posterior, with pelvic and pulmonary hypoplasia syndrome 9.5
1873 diabetes mellitus, transient neonatal, 1 9.5
1874 suppressor of tumorigenicity 11 9.5
1875 axenfeld-rieger syndrome, type 3 9.5
1876 histiocytosis-lymphadenopathy plus syndrome 9.5
1877 muenke syndrome 9.5
1878 type 2 diabetes mellitus 3 9.5
1879 brittle bone disorder 9.5
1880 mitochondrial complex v deficiency, nuclear type 1 9.5
1881 rheumatoid arthritis, systemic juvenile 9.5
1882 spastic paraplegia 11, autosomal recessive 9.5
1883 ataxia-telangiectasia-like disorder 1 9.5
1884 leber congenital amaurosis 4 9.5
1885 progressive familial heart block, type ib 9.5
1886 fanconi anemia, complementation group d1 9.5
1887 fasting insulin level quantitative trait locus 1 9.5
1888 diamond-blackfan anemia 2 9.5
1889 maturity-onset diabetes of the young, type 4 9.5
1890 vitiligo-associated multiple autoimmune disease susceptibility 1 9.5
1891 lipodystrophy, familial partial, type 7 9.5
1892 adiponectin, serum level of, quantitative trait locus 2 9.5
1893 adiponectin, serum level of, quantitative trait locus 3 9.5
1894 alzheimer disease 8 9.5
1895 celiac disease 5 9.5
1896 epilepsy, partial, with pericentral spikes 9.5
1897 duane-radial ray syndrome 9.5
1898 ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis 9.5
1899 peeling skin syndrome 4 9.5
1900 tropical calcific pancreatitis 9.5
1901 slowed nerve conduction velocity, autosomal dominant 9.5
1902 parathyroid carcinoma 9.5
1903 coronary heart disease 4 9.5
1904 corneal dystrophy, reis-bucklers type 9.5
1905 myocardial infarction 2 9.5
1906 lipodystrophy, congenital generalized, type 1 9.5
1907 avascular necrosis of femoral head, primary, 1 9.5
1908 carney complex variant 9.5
1909 mitochondrial trifunctional protein deficiency 9.5
1910 long-chain 3-hydroxyacyl-coa dehydrogenase deficiency 9.5
1911 salt and pepper developmental regression syndrome 9.5
1912 telomere length, mean leukocyte 9.5
1913 chromosome 3q29 deletion syndrome 9.5
1914 syndactyly, mesoaxial synostotic, with phalangeal reduction 9.5
1915 short qt syndrome 3 9.5
1916 loeys-dietz syndrome 2 9.5
1917 mevalonic aciduria 9.5
1918 potocki-lupski syndrome 9.5
1919 pulmonary alveolar proteinosis, acquired 9.5
1920 major affective disorder 4 9.5
1921 corticosteroid-binding globulin deficiency 9.5
1922 major affective disorder 5 9.5
1923 major affective disorder 6 9.5
1924 waardenburg syndrome, type 2e 9.5
1925 skin/hair/eye pigmentation, variation in, 9 9.5
1926 chromosome 15q13.3 deletion syndrome 9.5
1927 trehalase deficiency 9.5
1928 immunodeficiency 68 9.5
1929 joubert syndrome 8 9.5
1930 major affective disorder 8 9.5
1931 major affective disorder 9 9.5
1932 chromosome 1q21.1 deletion syndrome, 1.35-mb 9.5
1933 type 1 diabetes mellitus 22 9.5
1934 lipodystrophy, congenital generalized, type 3 9.5
1935 hearing loss, noise-induced 9.5
1936 macs syndrome 9.5
1937 short-rib thoracic dysplasia 3 with or without polydactyly 9.5
1938 polycystic kidney disease 2 with or without polycystic liver disease 9.5
1939 brachydactyly, type e2 9.5
1940 autism 17 9.5
1941 myxoid liposarcoma 9.5
1942 hyperoxaluria, primary, type iii 9.5
1943 fetal encasement syndrome 9.5
1944 mammary-digital-nail syndrome 9.5
1945 cardiomyopathy, familial hypertrophic, 20 9.5
1946 hepatic lipase deficiency 9.5
1947 pyruvate dehydrogenase e1-beta deficiency 9.5
1948 retinal arterial macroaneurysm with supravalvular pulmonic stenosis 9.5
1949 microcephaly, epilepsy, and diabetes syndrome 1 9.5
1950 mannose-binding lectin deficiency 9.5
1951 ras-associated autoimmune leukoproliferative disorder 9.5
1952 pseudohypoaldosteronism, type iie 9.5
1953 cerebellar ataxia, neuropathy, and vestibular areflexia syndrome 9.5
1954 bone marrow failure syndrome 1 9.5
1955 membranous nephropathy 9.5
1956 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.5
1957 riboflavin deficiency 9.5
1958 facial dysmorphism, immunodeficiency, livedo, and short stature 9.5
1959 developmental and epileptic encephalopathy 94 9.5
1960 alacrima, achalasia, and mental retardation syndrome 9.5
1961 hypobetalipoproteinemia, familial, 1 9.5
1962 vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome 9.5
1963 alzheimer disease 19 9.5
1964 sting-associated vasculopathy, infantile-onset 9.5
1965 monocarboxylate transporter 1 deficiency 9.5
1966 chronic mountain sickness 9.5
1967 noonan syndrome 10 9.5
1968 heart and brain malformation syndrome 9.5
1969 nevus comedonicus 9.5
1970 short stature, developmental delay, and congenital heart defects 9.5
1971 sessile serrated polyposis cancer syndrome 9.5
1972 aniridia 2 9.5
1973 mulchandani-bhoj-conlin syndrome 9.5
1974 rahman syndrome 9.5
1975 central centrifugal cicatricial alopecia 9.5
1976 juvenile arthritis 9.5
1977 amed syndrome, digenic 9.5
1978 hypercholanemia, familial, 2 9.5
1979 bartsocas-papas syndrome 2 9.5
1980 tendinosis 9.5
1981 autoimmune uveitis 9.5
1982 rocky mountain spotted fever 9.5
1983 dengue shock syndrome 9.5
1984 tick-borne encephalitis 9.5
1985 arrhythmogenic right ventricular cardiomyopathy 9.5
1986 lissencephaly 9.5
1987 periventricular nodular heterotopia 9.5
1988 multinodular goiter 9.5
1989 visceral heterotaxy 9.5
1990 severe congenital neutropenia 9.5
1991 tooth agenesis 9.5
1992 intestinal schistosomiasis 9.5
1993 extrapulmonary tuberculosis 9.5
1994 early infantile epileptic encephalopathy 9.5
1995 zollinger-ellison syndrome 9.5
1996 primary progressive multiple sclerosis 9.5
1997 atrioventricular block 9.5
1998 third-degree atrioventricular block 9.5
1999 hemorrhagic cystitis 9.5
2000 fibroma 9.5
2001 pancreatic agenesis 9.5
2002 syndromic intellectual disability 9.5
2003 ovarian serous carcinoma 9.5
2004 uterine corpus endometrial carcinoma 9.5
2005 autosomal recessive cerebellar ataxia 9.5
2006 hereditary ataxia 9.5
2007 interleukin-7 receptor alpha deficiency 9.5
2008 munchausen by proxy 9.5
2009 estrogen-receptor negative breast cancer 9.5
2010 connective tissue benign neoplasm 9.5
2011 gamma-amino butyric acid metabolism disorder 9.5
2012 ischemic colitis 9.5
2013 lymphocytic colitis 9.5
2014 clostridium difficile colitis 9.5
2015 autosomal dominant intellectual developmental disorder 9.5
2016 transient neonatal diabetes mellitus 9.5
2017 respiratory allergy 9.5
2018 penicillin allergy 9.5
2019 mitochondrial complex ii deficiency 9.5
2020 luminal breast carcinoma a 9.5
2021 spinal disease 9.5
2022 hyperekplexia 9.5
2023 syndromic x-linked intellectual disability cabezas type 9.5
2024 x-linked intellectual disability-psychosis-macroorchidism syndrome 9.5
2025 ectopic cushing syndrome 9.5
2026 mucositis 9.5
2027 gastroesophageal adenocarcinoma 9.5
2028 thyroid gland anaplastic carcinoma 9.5
2029 bronchiectasis 3 9.5
2030 dedifferentiated liposarcoma 9.5
2031 kleefstra syndrome 9.5
2032 benign teratoma 9.5
2033 tongue carcinoma 9.5
2034 rasopathy 9.5
2035 prothrombin thrombophilia 9.5
2036 transverse myelitis 9.5
2037 chronic spontaneous urticaria 9.5
2038 erythema nodosum 9.5
2039 acute erythroid leukemia 9.5
2040 intermittent asthma 9.5
2041 persistent moderate asthma 9.5
2042 environmental induced asthma 9.5
2043 low grade glioma 9.5
2044 acute necrotizing pancreatitis 9.5
2045 non-severe covid-19 9.5
2046 papillary tumor of the pineal region 9.5
2047 sitosterolemia 9.5
2048 postural orthostatic tachycardia syndrome 9.5
2049 sting-associated vasculopathy with onset in infancy 9.5
2050 familial adult myoclonic epilepsy 9.5
2051 non-syndromic x-linked intellectual disability 93 9.5
2052 duodenum cancer 9.5
2053 nodular malignant melanoma 9.5
2054 pigmentation disease 9.5
2055 dermatomyositis 9.5
2056 pleurisy 9.5
2057 mumps 9.5
2058 blepharophimosis 9.5
2059 yaws 9.5
2060 tonsillitis 9.5
2061 nasopharyngitis 9.5
2062 esophageal atresia 9.5
2063 intestinal atresia 9.5
2064 charcot-marie-tooth disease 9.5
2065 protein-losing enteropathy 9.5
2066 separation anxiety disorder 9.5
2067 malignant hypertension 9.5
2068 voyeurism 9.5
2069 salivary gland disease 9.5
2070 tethered spinal cord syndrome 9.5
2071 tooth disease 9.5
2072 benign essential hypertension 9.5
2073 obsessive-compulsive personality disorder 9.5
2074 impulse control disorder 9.5
2075 alport syndrome 9.5
2076 discitis 9.5
2077 depersonalization disorder 9.5
2078 t cell deficiency 9.5
2079 microcytic anemia 9.5
2080 arteriovenous malformation 9.5
2081 gingival recession 9.5
2082 alternating exotropia 9.5
2083 exotropia 9.5
2084 sciatic neuropathy 9.5
2085 cardiac tamponade 9.5
2086 diabetic autonomic neuropathy 9.5
2087 suppurative otitis media 9.5
2088 heart cancer 9.5
2089 limb-girdle muscular dystrophy 9.5
2090 emery-dreifuss muscular dystrophy 9.5
2091 bronchial disease 9.5
2092 chronic laryngitis 9.5
2093 clubfoot 9.5
2094 coronary artery vasospasm 9.5
2095 tinea cruris 9.5
2096 synostosis 9.5
2097 lymphocytic choriomeningitis 9.5
2098 common variable immunodeficiency 9.5
2099 descending colon cancer 9.5
2100 anisometropia 9.5
2101 cough variant asthma 9.5
2102 endocrine exophthalmos 9.5
2103 spinal muscular atrophy 9.5
2104 entropion 9.5
2105 tinea pedis 9.5
2106 lesion of sciatic nerve 9.5
2107 von willebrand's disease 9.5
2108 hemolytic-uremic syndrome 9.5
2109 potter's syndrome 9.5
2110 nephrocalcinosis 9.5
2111 acoustic neuroma 9.5
2112 respiratory syncytial virus infectious disease 9.5
2113 migraine without aura 9.5
2114 ancylostomiasis 9.5
2115 choreatic disease 9.5
2116 sialolithiasis 9.5
2117 central nervous system leukemia 9.5
2118 leukostasis 9.5
2119 balanitis 9.5
2120 renal osteodystrophy 9.5
2121 periventricular leukomalacia 9.5
2122 mechanical entropion 9.5
2123 crescentic glomerulonephritis 9.5
2124 allergic bronchopulmonary aspergillosis 9.5
2125 nontoxic goiter 9.5
2126 right bundle branch block 9.5
2127 mesenteric vascular occlusion 9.5
2128 typhoid fever 9.5
2129 klebsiella pneumonia 9.5
2130 intestinal tuberculosis 9.5
2131 congenital toxoplasmosis 9.5
2132 ehlers-danlos syndrome 9.5
2133 diamond-blackfan anemia 9.5
2134 pure red-cell aplasia 9.5
2135 neurosarcoidosis 9.5
2136 coccidioidomycosis 9.5
2137 supraglottis cancer 9.5
2138 balanitis xerotica obliterans 9.5
2139 osteopetrosis 9.5
2140 hypermobility syndrome 9.5
2141 sick sinus syndrome 9.5
2142 childhood type dermatomyositis 9.5
2143 acute cholangitis 9.5
2144 noonan syndrome with multiple lentigines 9.5
2145 pleuropneumonia 9.5
2146 norwegian scabies 9.5
2147 autosomal dominant cerebellar ataxia 9.5
2148 glossopharyngeal neuralgia 9.5
2149 cerebral degeneration 9.5
2150 root resorption 9.5
2151 axenfeld-rieger syndrome 9.5
2152 hereditary angioedema 9.5
2153 aggressive periodontitis 9.5
2154 lymphangioma 9.5
2155 colon lymphoma 9.5
2156 nodular nonsuppurative panniculitis 9.5
2157 fungal infectious disease 9.5
2158 renovascular hypertension 9.5
2159 mental depression 9.5
2160 lymphadenitis 9.5
2161 spontaneous tension pneumothorax 9.5
2162 histoplasmosis 9.5
2163 status epilepticus 9.5
2164 urethral stricture 9.5
2165 hepatitis d 9.5
2166 hereditary multiple exostoses 9.5
2167 vulva squamous cell carcinoma 9.5
2168 ectodermal dysplasia 9.5
2169 tularemia 9.5
2170 brain germinoma 9.5
2171 vaginitis 9.5
2172 essential thrombocythemia 9.5
2173 thrombocytosis 9.5
2174 focal epilepsy 9.5
2175 granulomatous hepatitis 9.5
2176 ankylosis 9.5
2177 pharyngitis 9.5
2178 motor neuron disease 9.5
2179 generalized atherosclerosis 9.5
2180 hyperpituitarism 9.5
2181 central retinal vein occlusion 9.5
2182 hereditary spastic paraplegia 9.5
2183 motor peripheral neuropathy 9.5
2184 enamel erosion 9.5
2185 orchitis 9.5
2186 adenomyoma 9.5
2187 papillary serous adenocarcinoma 9.5
2188 lymphangiosarcoma 9.5
2189 pigmented villonodular synovitis 9.5
2190 phimosis 9.5
2191 epidermolysis bullosa 9.5
2192 skin atrophy 9.5
2193 cerebellar disease 9.5
2194 bruxism 9.5
2195 melancholia 9.5
2196 euthyroid sick syndrome 9.5
2197 glucosephosphate dehydrogenase deficiency 9.5
2198 cervix carcinoma 9.5
2199 cryoglobulinemia 9.5
2200 mucinous adenocarcinoma 9.5
2201 allergic contact dermatitis 9.5
2202 high grade glioma 9.5
2203 early myoclonic encephalopathy 9.5
2204 gingival overgrowth 9.5
2205 thoracic outlet syndrome 9.5
2206 papillary carcinoma 9.5
2207 gastrointestinal system cancer 9.5
2208 anus disease 9.5
2209 tenosynovial giant cell tumor 9.5
2210 scleredema adultorum 9.5
2211 skin benign neoplasm 9.5
2212 progressive muscular atrophy 9.5
2213 jejunal neoplasm 9.5
2214 myelitis 9.5
2215 complex regional pain syndrome 9.5
2216 ovarian cystadenoma 9.5
2217 mixed germ cell cancer 9.5
2218 temporal lobe epilepsy 9.5
2219 osteitis fibrosa 9.5
2220 inappropriate adh syndrome 9.5
2221 cerebritis 9.5
2222 mammary paget's disease 9.5
2223 breast adenocarcinoma 9.5
2224 mastocytosis 9.5
2225 appendix adenocarcinoma 9.5
2226 kallmann syndrome 9.5
2227 lung benign neoplasm 9.5
2228 cervical adenocarcinoma 9.5
2229 cervical squamous cell carcinoma 9.5
2230 granuloma annulare 9.5
2231 porokeratosis 9.5
2232 cranial nerve palsy 9.5
2233 colonic pseudo-obstruction 9.5
2234 vulvitis 9.5
2235 bladder urothelial carcinoma 9.5
2236 linitis plastica 9.5
2237 duodenogastric reflux 9.5
2238 erythrasma 9.5
2239 biliary dyskinesia 9.5
2240 syphilis 9.5
2241 systemic scleroderma 9.5
2242 mutism 9.5
2243 pyoderma 9.5
2244 microsporidiosis 9.5
2245 polyradiculoneuropathy 9.5
2246 granulomatous dermatitis 9.5
2247 somatostatinoma 9.5
2248 central nervous system germinoma 9.5
2249 macular retinal edema 9.5
2250 bartter disease 9.5
2251 chromophobe renal cell carcinoma 9.5
2252 pseudohypoaldosteronism 9.5
2253 myotonic disease 9.5
2254 bile duct cancer 9.5
2255 ulnar neuropathy 9.5
2256 epidermolysis bullosa simplex 9.5
2257 brain edema 9.5
2258 calciphylaxis 9.5
2259 somatoform disorder 9.5
2260 vasculogenic impotence 9.5
2261 diffuse glomerulonephritis 9.5
2262 immune-complex glomerulonephritis 9.5
2263 cavernous hemangioma 9.5
2264 small intestine adenocarcinoma 9.5
2265 renal pelvis carcinoma 9.5
2266 klatskin's tumor 9.5
2267 postpoliomyelitis syndrome 9.5
2268 alcoholic pancreatitis 9.5
2269 optic nerve glioma 9.5
2270 ganglioglioma 9.5
2271 dermoid cyst of ovary 9.5
2272 arteriosclerosis obliterans 9.5
2273 uterine corpus sarcoma 9.5
2274 aortic disease 9.5
2275 demyelinating polyneuropathy 9.5
2276 intestinal disease 9.5
2277 anterograde amnesia 9.5
2278 functioning pituitary adenoma 9.5
2279 testicular germ cell cancer 9.5
2280 mediastinal cancer 9.5
2281 retinal disease 9.5
2282 gastric liposarcoma 9.5
2283 median neuropathy 9.5
2284 nerve compression syndrome 9.5
2285 pyosalpinx 9.5
2286 adult lymphoma 9.5
2287 esophageal disease 9.5
2288 chronic lymphocytic leukemia/small lymphocytic lymphoma 9.5
2289 central pontine myelinolysis 9.5
2290 acral lentiginous melanoma 9.5
2291 double outlet right ventricle 9.5
2292 pulmonary valve stenosis 9.5
2293 viral encephalitis 9.5
2294 progressive bulbar palsy 9.5
2295 juvenile pilocytic astrocytoma 9.5
2296 hepatoblastoma 9.5
2297 pituitary hypoplasia 9.5
2298 peptic ulcer perforation 9.5
2299 pancreatic intraductal papillary-colloid carcinoma 9.5
2300 carotid artery occlusion 9.5
2301 cocaine abuse 9.5
2302 osteochondritis dissecans 9.5
2303 whipple disease 9.5
2304 mucormycosis 9.5
2305 acute cor pulmonale 9.5
2306 nervous system disease 9.5
2307 vein disease 9.5
2308 genital herpes 9.5
2309 seborrheic dermatitis 9.5
2310 erythema infectiosum 9.5
2311 actinic keratosis 9.5
2312 neuromyelitis optica 9.5
2313 rosacea 9.5
2314 chorioretinitis 9.5
2315 severe nonproliferative diabetic retinopathy 9.5
2316 ritter's disease 9.5
2317 cutaneous leishmaniasis 9.5
2318 visceral leishmaniasis 9.5
2319 speech disorder 9.5
2320 urea cycle disorder 9.5
2321 primary cerebellar degeneration 9.5
2322 taylor's syndrome 9.5
2323 tracheitis 9.5
2324 blepharitis 9.5
2325 uterine corpus cancer 9.5
2326 dacryoadenitis 9.5
2327 krukenberg carcinoma 9.5
2328 senile cataract 9.5
2329 tenosynovitis 9.5
2330 hydrops of gallbladder 9.5
2331 eustachian tube disease 9.5
2332 postcholecystectomy syndrome 9.5
2333 trichinosis 9.5
2334 refractive error 9.5
2335 accommodative esotropia 9.5
2336 esotropia 9.5
2337 miliary tuberculosis 9.5
2338 hydrocele 9.5
2339 cocaine dependence 9.5
2340 alk-related neuroblastic tumor susceptibility 9.5
2341 chd2-related neurodevelopmental disorders 9.5
2342 chd8-related neurodevelopmental disorder with overgrowth 9.5
2343 creatine deficiency disorders 9.5
2344 dnajc6 parkinson disease 9.5
2345 factor v leiden thrombophilia 9.5
2346 hist1h1e syndrome 9.5
2347 hereditary multiple osteochondromas 9.5
2348 mbd5 haploinsufficiency 9.5
2349 plod1-related kyphoscoliotic ehlers-danlos syndrome 9.5
2350 prss1-related hereditary pancreatitis 9.5
2351 primary pyruvate dehydrogenase complex deficiency 9.5
2352 rab18 deficiency 9.5
2353 spastic paraplegia 11 9.5
2354 16p11.2 duplication 9.5
2355 acute monoblastic leukemia 9.5
2356 aminoaciduria 9.5
2357 aneurysm of sinus of valsalva 9.5
2358 autoimmune enteropathy 9.5
2359 biemond syndrome 9.5
2360 binswanger's disease 9.5
2361 candida glabrata 9.5
2362 central congenital hypothyroidism 9.5
2363 chiari malformation 9.5
2364 chromosome 16 trisomy 9.5
2365 chromosome 16q duplication 9.5
2366 chromosome 1q deletion 9.5
2367 chromosome 5p duplication 9.5
2368 chromosome 6q duplication 9.5
2369 cocaine antenatal exposure 9.5
2370 coccygodynia 9.5
2371 congenital hydrocephalus 9.5
2372 coronary artery aneurysm 9.5
2373 distal renal tubular acidosis 9.5
2374 elective mutism 9.5
2375 enthesitis-related juvenile idiopathic arthritis 9.5
2376 fournier gangrene 9.5
2377 gas bloat syndrome 9.5
2378 hair-an syndrome 9.5
2379 heavy metal poisoning 9.5
2380 hemoglobin se disease 9.5
2381 hemophilic arthropathy 9.5
2382 idiopathic edema 9.5
2383 itch e3 ubiquitin ligase deficiency 9.5
2384 juvenile amyotrophic lateral sclerosis 9.5
2385 kikuchi disease 9.5
2386 macrophage activation syndrome 9.5
2387 myoclonus epilepsy 9.5
2388 neonatal meningitis 9.5
2389 pancreatitis, pediatric 9.5
2390 papular mucinosis 9.5
2391 pattern dystrophy 9.5
2392 pediatric autoimmune neuropsychiatric disorders associated with streptococcus in 9.5
2393 plagiocephaly 9.5
2394 post-traumatic epilepsy 9.5
2395 progressive encephalomyelitis with rigidity and myoclonus 9.5
2396 progressive transformation of germinal centers 9.5
2397 pure autonomic failure 9.5
2398 retinochoroidal coloboma 9.5
2399 retroperitoneal liposarcoma 9.5
2400 secondary adrenal insufficiency 9.5
2401 trochlear dysplasia 9.5
2402 uniparental disomy of chromosome 2 9.5
2403 uterine sarcoma 9.5
2404 wells syndrome 9.5
2405 corticosterone methyloxidase deficiency 9.5
2406 ataxia neuropathy spectrum 9.5
2407 central cord syndrome 9.5
2408 cerebral aneurysms 9.5
2409 cerebral arteriosclerosis 9.5
2410 cerebral hypoxia 9.5
2411 hemifacial spasm 9.5
2412 myoclonus 9.5
2413 audiogenic seizures 9.5
2414 cleft lip with or without cleft palate 9.5
2415 multicystic dysplastic kidney 9.5
2416 glycogen storage disease due to glucose-6-phosphatase deficiency 9.5
2417 familial long qt syndrome 9.5
2418 genetic neuromuscular disease 9.5
2419 systemic autoimmune disease 9.5
2420 adrenogenital syndrome 9.5
2421 orofacial clefting syndrome 9.5
2422 perioral myoclonia with absences 9.5
2423 immune complex mediated vasculitis 9.5
2424 low-grade astrocytoma 9.5
2425 rare lymphatic malformation 9.5
2426 rare hereditary hemochromatosis 9.5
2427 congenital erosive and vesicular dermatosis 9.5
2428 cerebral sinovenous thrombosis 9.5
2429 silent pituitary adenoma 9.5
2430 lmna-related cardiocutaneous progeria syndrome 9.5
2431 congenital pseudoarthrosis of the tibia 9.5
2432 acyl-coa dehydrogenase deficiency 9.5
2433 paracetamol poisoning 9.5
2434 homozygous familial hypercholesterolemia 9.5
2435 osteonecrosis of the jaw 9.5
2436 avascular necrosis 9.5
2437 primitive portal vein thrombosis 9.5
2438 secondary sclerosing cholangitis 9.5
2439 semicircular canal dehiscence syndrome 9.5
2440 idiopathic gastroparesis 9.5
2441 disorder of energy metabolism 9.5
2442 disorder of purine metabolism 9.5
2443 anterior cutaneous nerve entrapment syndrome 9.5
2444 serotonin syndrome 9.5
2445 rare intellectual disability 9.5
2446 renal dysplasia 9.5
2447 microtia 9.5
2448 lumbar syndrome 9.5
2449 autosomal trisomy 9.5
2450 paternal uniparental disomy 9.5
2451 rare tumor 9.5
2452 dementia pugilistica 9.5
2453 polyploidy 9.5
2454 severe immune-mediated enteropathy 9.5
2455 monosomy 22 9.5
2456 hypomyelination of early myelinating structures 9.5
2457 immune-mediated thrombotic thrombocytopenic purpura 9.5
2458 x-linked emery-dreifuss muscular dystrophy 9.5
2459 colobomatous microphthalmia 9.5
2460 acquired lipodystrophy 9.5
2461 intestinal polyposis syndrome 9.5
2462 undetermined colitis 9.5
2463 brain inflammatory disease 9.5
2464 multiple congenital anomalies/dysmorphic syndrome-intellectual disability 9.5
2465 neurogenic thoracic outlet syndrome 9.5
2466 cpe-related prader-willi-like syndrome 9.5
2467 hyperphenylalaninemia 9.5

Graphical network of the top 20 diseases related to Body Mass Index Quantitative Trait Locus 11:



Diseases related to Body Mass Index Quantitative Trait Locus 11

Symptoms & Phenotypes for Body Mass Index Quantitative Trait Locus 11

Human phenotypes related to Body Mass Index Quantitative Trait Locus 11:

30 (showing 3, show less)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 obesity 30 HP:0001513
2 decreased resting energy expenditure 30 HP:0012340
3 increased waist to hip ratio 30 HP:0031819

Clinical features from OMIM®:

300306 601665 (Updated 08-Dec-2022)

UMLS symptoms related to Body Mass Index Quantitative Trait Locus 11:


symptoms; high weight; obesity, metabolically benign; monogenic obesity

GenomeRNAi Phenotypes related to Body Mass Index Quantitative Trait Locus 11 according to GeneCards Suite gene sharing:

25 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Reduced mammosphere formation GR00396-S 9.23 ABCC8 AGRP DNMT3A GHRL GNAS MC4R

MGI Mouse Phenotypes related to Body Mass Index Quantitative Trait Locus 11:

45 (showing 13, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.4 ABCC8 ADRB2 ADRB3 AGRP BBIP1 BRCA2
2 growth/size/body region MP:0005378 10.32 ABCC8 ADRB2 ADRB3 AGRP BBIP1 BRCA2
3 adipose tissue MP:0005375 10.31 ADRB2 ADRB3 AGRP CARTPT DNMT3A ENPP1
4 nervous system MP:0003631 10.27 ADRB2 AGRP BBIP1 BRCA2 DNMT3A ENPP1
5 endocrine/exocrine gland MP:0005379 10.17 ABCC8 ADRB2 ADRB3 BBIP1 BRCA2 CARTPT
6 no phenotypic analysis MP:0003012 10.11 ABCC8 ADRB2 AGRP GNAS MC4R POLG
7 liver/biliary system MP:0005370 10.11 ADRB2 AGRP ENPP1 GNAS MC4R NR0B2
8 muscle MP:0005369 10.08 ADRB2 DNMT3A ENPP1 GNAS POLG PPARG
9 neoplasm MP:0002006 10.07 BRCA2 GNAS MC4R POLG POMC PPARG
10 cardiovascular system MP:0005385 10 ABCC8 ADRB2 CARTPT ENPP1 GNAS MC4R
11 behavior/neurological MP:0005386 10 ADRB2 ADRB3 AGRP BBIP1 BRCA2 CARTPT
12 skeleton MP:0005390 9.73 ADRB2 BBIP1 BRCA2 CARTPT DNMT3A ENPP1
13 integument MP:0010771 9.32 ADRB2 BBIP1 BRCA2 ENPP1 GNAS POLG

Drugs & Therapeutics for Body Mass Index Quantitative Trait Locus 11

Drugs for Body Mass Index Quantitative Trait Locus 11 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 934, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
2
Lactitol Approved, Investigational Phase 4 585-86-4 157355
3
Dexlansoprazole Approved, Investigational Phase 4 138530-94-6 9578005
4
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
5
Indapamide Approved Phase 4 26807-65-8 3702
6
Insulin lispro Approved Phase 4 133107-64-9 16132438
7
Erythromycin Approved, Investigational, Vet_approved Phase 4 114-07-8 12560
8
Insulin aspart Approved Phase 4 116094-23-6 16132418
9
Hydroxychloroquine Approved Phase 4 118-42-3 3652
10
Metyrapone Approved, Investigational Phase 4 54-36-4 4174
11
Cyproterone acetate Approved, Investigational Phase 4 427-51-0 9880
12
Tolnaftate Approved, Investigational, Vet_approved Phase 4 2398-96-1 5510
13
Phentermine Approved, Illicit Phase 4 122-09-8 4771
14
Rosiglitazone Approved, Investigational Phase 4 122320-73-4, 155141-29-0 77999
15
Coal tar Approved Phase 4 8007-45-2
16
Loperamide Approved Phase 4 53179-11-6 3955
17
Heparin, bovine Approved, Investigational, Withdrawn Phase 4 9005-49-6 22833565 9812414 772
18
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
19
Levoleucovorin Approved, Experimental, Investigational Phase 4 68538-85-2, 58-05-9, 73951-54-9 149436 6006
20
Calcium carbonate Approved, Investigational Phase 4 471-34-1
21
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
22 Tomato Approved Phase 4
23
Dapagliflozin Approved Phase 4 461432-26-8 9887712
24
Infliximab Approved Phase 4 170277-31-3
25
Octreotide Approved, Investigational Phase 4 83150-76-9 383414 6400441
26
Saxagliptin Approved Phase 4 361442-04-8 11243969
27
Ethinylestradiol Approved Phase 4 57-63-6 5991
28
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
29
Moxifloxacin Approved, Investigational Phase 4 186826-86-8, 354812-41-2, 151096-09-2 152946
30
Desflurane Approved Phase 4 57041-67-5 42113
31
Zonisamide Approved, Investigational Phase 4 68291-97-4 5734
32
Apixaban Approved Phase 4 503612-47-3 10182969
33
Parathyroid hormone Approved, Investigational Phase 4 9002-64-6
34 Orange Approved Phase 4
35
Drospirenone Approved Phase 4 67392-87-4 68873
36
Glyburide Approved Phase 4 10238-21-8 3488
37
Atorvastatin Approved Phase 4 134523-00-5 60823
38
Risedronic acid Approved, Investigational Phase 4 105462-24-6 5245
39
Memantine Approved, Investigational Phase 4 41100-52-1, 19982-08-2 4054
40
Cyclophosphamide Approved, Investigational Phase 4 50-18-0, 6055-19-2 2907
41
Letrozole Approved, Investigational Phase 4 112809-51-5 3902
42
Galantamine Approved Phase 4 357-70-0, 1953-04-4 9651
43
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
44
Anidulafungin Approved, Investigational Phase 4 166663-25-8 166548
45
Chenodeoxycholic acid Approved Phase 4 474-25-9 10133
46
Bismuth subsalicylate Approved, Vet_approved Phase 4 14882-18-9 53629521 16682734
47
Clarithromycin Approved Phase 4 81103-11-9 84029
48
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
49
Nadroparin Approved, Investigational Phase 4
50
Neostigmine Approved, Vet_approved Phase 4 59-99-4 4456 5824
51
Micafungin Approved, Investigational Phase 4 235114-32-6 477468
52
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307